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PHYSICAL, CHEMICAL AND IMMUNOCHEMICAL CHARACTERIZATION 
OF HUMAN PLASMA LOW DENSITY LIPOPROTEINS
CHAPTER I 
INTRODUCTION
It has long been recognized that the blood lipids are combined 
with other substances rather than existing in the free state. These com­
plexes serve as the vehicles for maintenance and transport of lipids in 
the aqueous plasma. Numerous early investigators, including Nerking (l). 
Hardy (2), Haslam (3), Chick (4), Theorell (5) and Sorensen (6) studied 
the distribution of various lipids during investigations of the precipi­
tation of serum protein fractions and noted the presence of cholesterol 
and phospholipid in the water-insoluble euglobulin subfractions. How­
ever, it was not until 1929 that a lipoprotein which displayed a rela­
tively constant chemical composition was isolated from horse plasma by 
Macheboeuf (7). Lipoprotein research has developed rapidly since 1940 
and some eighteen times as much work on lipoproteins has been published 
in the five year period 1957-1962 as compared to the 1947-1952 period 
(8).
Classification of Lipoproteins 
The most striking aspect of plasma lipoprotein preparations is
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their heterogeneity. They differ in density and composition ( 9 ,  1 0 ) ,  
electrophoretic mobility (ll), protein moiety ( 1 2 ,  1 3 ,  1 4 ,  1 5 ) ,  particle 
size. ( 1 6 ) ,  sedimentation coefficient, S , and flotation coefficient, S f  
( 1 7 ,  1 8 ) .  This heterogeneity renders the exact definition of lipoprotein 
classes difficult. At the present time there are five recognized classes, 
based on ultracentrifugal isolation techniques; (l) chylomicrons (d =
0 . 9 4 ,  (2) very low-density lipoproteins (VLDL, d = 0 . ‘9 B ) ,  (S) low-density 
lipoproteins (LDL, d = 1 . 0 3 ) ,  ( 4 )  high-density lipoproteins (HDL, d = 
1. 12) ,  and (5) very high-density lipoproteins (VHDL, d > 1 . 2 1 0 ) .  Each 
class, however, is still heterogeneous with respect to protein moiety, 
composition, density, particle size, sedimentation, and flotation rate.
The usual criteria of purity and homogeneity are not applicable. Chylo­
microns are described as the lipoproteins of S f  10,000 + 5,000 by Oncley
to
(16) and as lipoproteins of S f  > 400 by others (19). Chylomicrons with
0
Sf > 5,000 have particle sizes of 2500 A or more in diameter and molecular
gweights greater than 5 x 10 . Very low-density lipoproteins are those 
of S f  20-400 or of S f  20-5,000 (20). This group contains three different 
protein moieties; apolipoprotein A, apolipoprotein B, and apolipoprotein 
C (14). However, the high lipid content of this range (> 90%) renders 
the isolation of lipoproteins with specific protein moieties very diffi­
cult. Low-density lipoproteins are generally subdivided into two frac­
tions: (1) LDL isolated at solvent density range 1.006-1.019 g/ml, corre­
sponding to S f  12-20, and (2) LDL isolated at solvent density range 1.019-
1.063 g/ml, corresponding to S f  0-12 (19). Both fractions contain apo­
lipoprotein B as the major protein moiety. This class of lipoproteins 
is also designated as p-lipoproteins due to their electrophoretic mobil-
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ity, which is similar to that of p-globulin (21, 22). However, the pres­
ence of high-density lipoproteins (HDL) in the upper density range of LDL 
was recognized by Freeman et (23). DeLalla, Levin and Brown (24) 
found HDL in the LDL of density less than 1.063 g/ml from a patient with 
biliary cirrhosis. For this reason, only the purified LDL containing a 
single protein moiety, apolipoprotein B is designated as ApoB-LP in this 
study. High-density lipoproteins (HDL2 + HDLg) are lipoproteins isolated 
at the solvent density 1.063-1.125 g/ml and 1.125-1.20 g/ml (18, 23).
This class of lipoproteins contains mainly a-LP, the name having origi­
nated with the discovery that some serum lipids move with the a^-globulin 
in free electrophoresis (21, 22). The presence of p-LP was found in the 
density range 1.063-1.100 g/ml by Ayrault-Jarrier, ^  al. (25, 26), and 
was also noticed by Levy and Fredrickson (27). Very high-density lipo­
protein is the name given to the a-LP in the density range higher than
1.21 g/ml. DeLalla et (24) first noticed the presence of a-LP of 
density greater than 1.240 g/ml. Alaupovic ^  al. (28) isolated and char­
acterized the VHDL^ at density 1.210-1.250 g/ml and VHDL2 of density 
greater than 1.250 g/ml. Their results suggested that VHDL consists of 
lipid-protein complexes separable into two major groups characterized by 
the presence of apolipoprotein A and albumin, respectively, as lipid- 
carrying proteins.
Distribution of B-Lipoproteins 
The distribution of lipoproteins can best be illustrated by a 
typical pattern taken from a study by Freeman et (23) and reproduced 
in Figure 1. As mentioned in the previous section, lipoproteins in the 
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Figure 1. The ultracentrifugal spectrum of human serum lipo­
proteins .
Physical sizes of each lipoprotein class are illustrated by the 
electron micrographs. Lipoprotein hydrated density is indicated for each 
region of the serum lipoprotein spectrum (23).
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p-LP is not restricted to this range. They are found in lipoprotein seg­
ments up to the density of 1.10 g/ml (25, 26, 27) as well as in the VLDL 
and chylomicrons. Subfractionating VLDL at various centrifugal forces 
and times ("g min"), Gustafson et (14) found that only the subfraction 
of S f  20-50 contained a single protein moiety, apolipoprotein B. Maximum 
concentration of p-LF lies in the hydrated density range 1.030-1.045 g/ml 
for normal human serum or plasma. The distribution pattern varies con­
siderably with sex and age and varies slightly from individual to indi­
vidual (29). For hypercholesterolemic plasma the pattern shifts its max­
imum to the left, i.e., lower density. For normal plasma drawn after an
extended fast (20 hours), the maximum concentration shifts to the right,
i.e., higher density, as noticed in the present study. A two-dimensional 
distribution function of the p-lipoproteins of various density ranges was 
studied by Numa and Oncley (l6). Their plot of relative amounts of pro­
tein against lipoprotein density and size indicates an almost continuous
distribution of lipoproteins from density 0.947 to 1.041, with diameters
/ 0 0(assuming spherical shape) from about 1150 A to about 160 A.
Isolation of B-Lipoproteins 
The first fractionation of lipoproteins was performed by 
Macheboeuf (7) using the method of salt fractionation and manipulating 
both salt concentration and pH. Cohn et aT. (30) used successfully 
ethanol at low ionic strength, low temperature, and in conjunction with 
pH manipulation to fractionate lipoproteins. Beta-lipoproteins were 
present in fractions I, II and III and a-LP in fractions IV, V and VI.
The use of metal ions to decrease the solubility of protein salts in the 
water-organic solvent mixture resulted in a modified, faster method of
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fractionation (31, 32). However, Mills et _al. (33) observed that treat­
ment of Cohn's fractions I + II + III with concentrated salt solutions 
brought about the loss of some lipid components. They suggested that 
this was not a good method for the preparation of intact lipoproteins, 
but may be a useful route for the lipid-deficient preparations which are 
required for the investigation of lipoprotein structure.
Electrophoresis has also been used as a means of isolating lipo­
proteins. Blix, Tiselius, and Svensson (22) used free electrophoresis 
to separate p-LP from y-globulin. Kramer and Tiselius (34), Turba and 
Enenkel (35), and Durrum (36) introduced paper electrophoresis which has 
been widely applied in clinical work. However, it is not a preparative 
method. Starch block electrophoresis has been used by Kunkel and Slater 
(ll), but the difficulties of eluting the lipoproteins have limited the 
use of this technique. The newly developed polyacrylamide gel electro­
phoresis is now available also for work on a preparative scale (37). 
Reissell _et (38) developed the use of starch granules as a matrix 
for thin layer electrophoresis and coupled this with quantitative thin 
layer chromatography for the lipids extracted from lipid-containing bands 
in the starch electrophoretic patterns.
Lipoprotein research has been greatly stimulated since 1940 by 
the development of ultracentrifugation. An important ultracentrifugal 
technique was introduced by Gofman, Lindgren, and Elliott (l7). These 
investigators showed that the anomalous schlieren patterns which had been 
obtained with whole serum by McFarlane (39) and Pedersen (40) could be 
explained by the Johnston-Ogston effect (41) involving lipoproteins. 
Preparative ultracentrifugal flotation of the serum in solutions of in­
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creased density eliminated the anomalous schlieren patterns in the infra- 
natant fraction. The flotation technique has now been standardized by 
DeLalla and Gofman (l8) and DelGatto, Lindgren, and Nichols (42). Essen­
tially it consists of adjusting the density of serum (excluding the den­
sity contributed by the protein) to the desired point by the addition of 
salt or a salt solution of known density, and centrifuging the adjusted 
solution in a preparative rotor at 40,000-50,000 rpm. Different salts 
have been used, including sodium chloride, potassium bromide, and sodium 
bromide. The latter has been recommended by most workers because of its 
high solubility and its non-interference with nitrogen determinations.
The precipitation of lipoproteins by polyanions has been reported 
by several authors: Bernfeld (43); Burstein and Samaille (44, 45);
Burstein (46); Oncley, Walton, and Cornwell (47). Polyanions such as 
sulfated amylopectin, dextran sulfate, and heparin have been used to pre­
cipitate ApoB-LP in the presence of bivalent ions such as calcium chlo­
ride, magnesium chloride and manganese chloride. Oncley et (48), 
using a combination of dextran sulfate precipitation and ultracentrifu­
gation, found that the precipitated lipoproteins had an Sf range of 10- 
100 with a preponderance in the Sf 20-60 range. Cornwell and Kruger (49) 
studied the precipitation by sulfated polysaccharide and found that this 
polyanion precipitated the whole spectrum of low-density lipoproteins. 
Bernfeld _et al. (50) examined the precipitated p-lipoprotein complex and 
found marked changes in the electrophoretic mobilities. Granda (5l) also 
observed that the electrophoretic mobility of dextran sulfate precipitated 
p-LP was three times as high as that of p-LP in whole serum. This indi­
cated that the dextran sulfate could not be removed completely from p-LP.
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Gel filtration has been applied recently to the separation of 
p-LP from a-LP (52). Separation is based on diffusional partition of 
solutes between a stationary phase within the bed material and an exter­
nal mobile phase. Solute molecules which are small enough to penetrate
the porous gel beads are retarded relative to larger molecules which are 
unable to enter the pores. Among the bed materials available at present 
(e.g., latex rubber, starch, dextran, polyacrylamide), agar offers the 
largest pore size. Agarose, a neutral constituent of agar, has been 
chosen by many workers to avoid specific adsorption of solutes to the 
bed matrix.
Separation of the plasma lipoproteins by column chromatography 
has also been performed by several workers (53, 54, 55). Cramer (53) 
studied the isolation of p-LP by hydroxyapatite column chromatography 
and compared the results with those obtained by other methods.
Characterization of LDL or B-Lipoproteins 
Although p-lipoproteins isolated by any technique are heterogen­
eous in density, size, chemical composition, sedimentation and flotation
coefficients, they do possess some unique properties different from a-LP 
and from other proteins. The methods of characterization can be classi­
fied as (l) physical-chemical, (2) immunological, and (3) chemical.
Physical-Chemical Methods 
Electrophoresis. Beta-lipoproteins possess the same electro­
phoretic mobility as p-globulin in whole serum. Free boundary electro­
phoresis is a precise but expensive method, and therefore has not been 
used widely. Zone electrophoresis techniques are more frequently used.
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Paper electrophoresis is the least expensive and most widely applied in 
clinical work; however, the resolution is poor and the sensitivity is 
low. Cellulose acetate has gradually replaced paper. Starch gel, agar 
gel, and polyacrylamide gel all show higher resolving power than paper.
Ultracentrifugation. The variations in density of p-LP render 
them well suited for characterization in the analytical ultracentrifuge. 
Lipoproteins of different densities have correspondingly different flo­
tation coefficients ( S f ) ,  sedimentation coefficients ( S )  and diffusion 
coefficients (D). Diameter of the particles of a given density range can 
be calculated from the S f  value, assuming the particle to be a sphere. 
Molecular weight for a density range can be determined either by the 
Archibald method or calculated from the S/D value. The physical chemical 
data available for LDL fractions are shown in Table 1. Molecular weights 
of LDL fractions including light scattering results are shown in Table 2.
Immunological Methods
Immunology is the simplest but most sensitive method for char­
acterization of lipoproteins. It is also the most sensitive method of 
determining the degree of purity of the protein moiety in a given prepa­
ration, since the antigen-antibody interaction is protein specific. Both 
ApoA-LP and ApoB-LP contain similar lipid components and both are hetero­
geneous with respect to chemical composition and densities. A contamina­
tion of the low-density lipoprotein range by ^oA-LP can hardly be noticed 
by physical-chemical characterization or by determination of gross chem­
ical composition. Electrophoresis has been used more frequently than 
immunochemistry as the method for determining the purity of lipoproteins. 
However, the sensitivity of immunochemical methods is far superior to
TABLE 1
PHYSICAL CHEMICAL CHARACTERIZATION OF HUMAN PLASMA OR SERUM LDL
Fraction dg/ml ®20,w
°20,w





Sf 13 1.015 - - - - - (19)
Sf 12.1 1.016 - - - - - (19)
Sf 9.1 1.022 - - - - - (19)
Sf 4-10 - 5.9 - 1.7 - - (56)
Sf 8 - - 8.1 - 212 2.42 (57)
Sf 6-8 1.029 - - - - - (19)
oSf 6.4 - - 6.4 - 205 2.16 (57)
Sf 6.1 1.035 - - - - - (19)
Sf 5.9 - - 5.9 - - - (57)
Sf 4.1 1.041 - - - - - (19)
1.007-1.063 - - - - 350 + 25® - (58)
1.019-1.063 - - - - 185 - (58)
1.006-1.022 - - 14.9 - - - (59)
1.031-1.035 6.9 — - - (59)
Electron microscopy.
TABLE 2





minimum M. W. 
X  10-6 g/mole
Reference
Sf 13 - - 3.4 (19)
Sf 4-10 2.6 - - (56)
Sf 8.1 - 3.08 (pH 6.7) - (57)
Sf 7.9 1 ■ 3.20 - (60)
Sf 6.4 - 2.80 (pH 6.7) - (57)
Sf 6 - - 2.5 (19)
Sf 5.9 - 2.77 (pH 6.7) - (57)
Sf 4 - - 1.7 (19)
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those of electrophoretic techniques (see section of Results).
A number of investigators (12, 24, 61-67) have been able to pro­
duce antisera which will react with the a-LP but not with p-LP and, like­
wise, antisera which are specific to p-LP but not to a-LP. Gitlin et al. 
(68) found antigenic differences in separated narrow bands of LDL.
Aladjem et (12, 69) have obtained similar results by absorption, pre­
cipitation, and agar diffusion techniques. Lawrence and Shean (70) found 
two antigens more frequently than one in the LDL. However, Korngold et 
al. (65) and Levine (67) showed antigenic homogeneity of this lipoprotein 
class. Scanu et _al. (71) using agar immunoelectrophoresis and the agar 
double diffusion technique of Ouchterlony (72) found that lipoproteins 
with 0-20 were antigenically homogeneous. Blumberg et (73) also 
showed that all LDL possessed the same antigenic form.
Chemical Methods
Havel et al. (lO) and Cramer (74) showed that the chemical com­
position of p-LP varied considerably with age and sex. However, the 
weight ratio of total cholesterol (expressed as free cholesterol) to phos­
pholipid was found to be nearly a constant (1.25-1.41) for lipoproteins 
isolated from normal human serum at density range 1.019-1.063 g/ml.
Bragdon et (75) also obtained a similar value. Data on the chemical 
composition of p-LP available in current literature are summarized in 
Table 3. The results of phospholipid composition of LDL are shown in 
Table 4. The bound fatty acid components include palmitic, palmitoleic, 
stearic, oleic, linoleic, and arachidonic acid (23). In LDL with 0-20 
linoleic (50.7^) and oleic (18.2%) are the major cholesterol ester fatty 
acids; palmitic (30.1%) and linoleic (19.3%) are the major acids in the
TABLE 3








1.006-1.019 g/ml 26 6.5 35 - 18 15 (76)
1.019-1.063 g/ml 39.4 7.5 9.3 - 23.1 20.7 (75)
1.019-1.063 g/ml 38.0 8.1 - - 25.0 26.5 (77)
Preparation with 
Cornstarch 36.8 10.4 8.8 - 18.8 25.2 (78)
Chromatography on 
hydroxylapatite 38.5 7.5 9.0 - 22.0 23.0 (74)
Preparation with 
organic solvent 39.1 8.3 -
1
29.3 23.0 (79)
1.031-1.035 38 8 10 1 22 21 (80)
1.045-1.065 25.5 16 14 4 15 25 (81)
Sf 3-9 39.4 7.4 8.9 - 22.4 21.9 (49)
Sf 0-12 if) 48.4 10.2 8.0 - 17.1 16.3 (83)
Sf 0-12 (&) 50.8 9.9 6.4 - 17.1 15.8 (83)
co
TABLE 4
THE PERCENT COMPOSITION OF PHOSPHOLIPID OF HUMAN PLASMA OR SERUM LDL FRACTIONS
Fraction






1.019-1.063 66.3 4.1 25.3 4.4 (85)
1.019-1.063 (&) 37.5 12.0 45 5.5 (86)
1.019-1.063 (f) 58.5 8.5 29 4 (86)





Carbohydrates in p-LP have been studied by several workers. 
Rimington (88) determined the hexosamine content. Kirby (89) found that 
carbohydrate content was high in Cohn fractions III and IV-1. Epstein 
and Block (90) observed that the amount of glycoprotein, expressed in 
terms of hexosamine concentration, was less than 3 mg/lOO ml of serum in 
lipoproteins of density less than 1.063 g/ml. Marshall and Kummerow (91) 
reported the percent carbohydrate composition of LDL of the same density 
range: hexose 3.23^, hexosamine 1.2̂ , and sialic acid 0.353̂ . Abraham
et al. (92) isolated LDL and higher lipoprotein classes from chick sera 
and egg yolk lipoproteins and found that they contained bound galactose, 
mannose, glucosamine and sialic acid. Sialic acid and other carbohy­
drates were also studied by Schultze and Heide (93), Ayrault-Jarrier et 
al. (94) and Margolis and Langdon (95). The latter authors reported that 
sialic acid accounted for about 0.5% of the weight of delipidized p-LP.
Terminal amino acid of p-LP has been reported by several authors 
(96, 97) to be distinct from that of a-LP. These authors reported that 
the N-terminal amino acid for lipoproteins of density 1.019-1.063 g/ml 
was glutamic acid, and that of lipoproteins of density 1.063-1.210 g/ml 
was aspartic acid. Shore (60) confirmed these results but found a small 
amount of serine in addition to glutamic acid as N-terminal amino acids 
for LDL. He also found that the C-terminal amino acids for LDL and HDL 
were serine (with traces of alanine) and threonine, respectively. 
Rodbell's results (98) showed more heterogeneity in that glutamic acid, 
serine and threonine were all found as N-terminal amino acids for lipo­
proteins of density 1.019-1.063, and aspartic acid, serine and threonine
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for HDL (1.063-1.21 g/ml).
Amino acid composition has been studied by Shore and Shore (99) 
who measured the fluorescence of amino acid-sugar complexes developed by 
spraying chromatograms of protein hydrolysates with a xylose sodium bi­
sulfite spray. They also measured the DNP derivatives of the hydrolysate 
amino acids. The authors concluded "the proteins of the lipoproteins of 
hydrated density 1.006-0.96 g/ml (Sf 20-400), 1.040-1.006 g/ml (Ŝ  4-20), 
1.015 g/ml (Sf 13) and 1.035 g/ml (Sf 6) are of quantitatively identical 
amino acid composition and very similar, if not identical to that of high 
density lipoproteins of hydrated density 1.075 and 1.145 g/ml". However, 
some differences in amino acid composition between LDL and HDL were re­
ported by Brown et al_. (97). If the elegant results reported by Margolis 
and Langdon (95) on p-LP isolated by dextran sulfate precipitation are 
compared to those of Scanu and Hughes on a-LP (lOO), differences between 
the amino acid composition of a-LP and p-LP are definitely indicated.
There is a striking difference in the values for isoleucine, aspartic 
acid, and phenylalanine. Granda and Scanu (lOl) concluded recently that 
the amino acid composition of LDL of the density ranges 1.006-1.019 g/ml 
and 1.019-1.063 g/ml showed no difference.
Polymorphism of Human LDL
Since the discovery in 1961 by Allison and Blumbery (102) of 
isoprecipitins against LDL in the serum of a multitransfused patient, it 
has become obvious that there exists an immunological heterogeneity among 
LDL of human subjects. Immunological types are genetically determined 
and display group specificity (102). A considerable number of polymorphic 
LDL-variants has been described (103-106).
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Study of B-Lipoprotein Structure
It is not within the scope of this study to discuss the normal 
or deranged lipoprotein metabolism with all its possible consequences on 
the development of atherosclerosis. However, the correlation of the el­
evated blood cholesterol concentration with the elevation of p-LP in 
atherosclerotic patients has brought to our attention the importance of 
p-LP and, correspondingly, the importance of the structures of p-LP and 
apolipoprotein B.
In order to study the protein structure, the lipids must first 
be removed from a lipoprotein. Avigan (l09) used peroxide-free ether to 
delipidize solutions of p-LP and found that nearly all of the cholesterol, 
most of the triglycerides, but little of the phospholipids were removed 
into the ether phase. Scanu et (llO), using ethanol-ether (3:1 v/v), 
delipidized a-LP at -20° C and obtained a soluble protein moiety practi­
cally free of lipid. However, the same procedure applied to p-LP failed 
to yield a soluble protein. Grundy et al. (ill, 112) used the modified 
Avigan's two-phase procedure with lyophilization of the aqueous phase and 
found that the partially delipidized LDL of a broad density range showed 
two peaks in the analytical ultracentrifuge. If a narrow density range 
of LDL was used, however, the delipidized material showed only a single 
peak. Granda and Scanu (lOl) obtained solubilized apolipoprotein B by 
delipidizing p-LP either partially or totally in the presence of excess 
sodium dodecyl sulfate (SDS). The delipidized material was then dialyzed 
against Tris buffer extensively (10-12 days). They were unable to remove 
the SDS completely. Although the totally and partially delipidized LDL 
possessed two ultracentrifugal components, the succinylated apolipoprotein
18
B showed only a single peak of 7.2S. The totally delipidized p-LP ex­
hibited affinity for micellar phospholipids, and the partially delipid­
ized p-LP would remove and bind cholesterol from a heptane solution (51).
The currently available model of an LDL is that set forth by 
Vandenheuvel (113) who calculated it from the data of Oncley et (114).
Vandenheuvel suggested that a water containing sphere with diameter of
o 0126 A was covered by lipids with an annular space of 22 A. The external
shell, formed by hydrated protein was 7 % thick, resulting in a final 
LDL sphere with a diameter of 185 %. However, this calculation was based 
on a molecular weight of an anhydrous LDL of 1.3 x 10^ g/mole with a water 
content of 60^ of its dry weight. This percentage of water was consider­
ed later to be too high (16). Therefore this model would be invalid. So 
far, no other models of LDL structure have appeared in the literature.
The structure of p-LP is still far from clear. The elucidation 
of structure in a complex molecule such as a lipoprotein requires detail­
ed information regarding the molecular weight, particle size, chemical 
composition and physical or chemical properties. For p-LP such informa­
tion must cover a wide range of different particles. A comprehensive 
study on the chemical composition and physical properties of LDL isolated 
at narrow density ranges has not been reported in the literature; such 
studies have been confined either to the broad range or only to a few seg­
ments of LDL.
Therefore, in order to provide such information the purpose of 
the present study is to isolate p-LP subfractions, to determine their 
chemical composition and physical-chemical properties and to characterize 
their protein moieties. It is hoped that such information would contrib­
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ute to a better understanding of the relationship between subtractions 
differing in the hydrated density and lipid composition, establish pos­
sibly the concept of a single apolipoprotein as the most characteristic 
feature of this class of lipoproteins, and offer thus a new insight into 
the structural aspects of LDL.
CHAPTER II 
MATERIALS AND METHODS 
Materials 
Human Plasma
Venous blood was obtained from healthy males and females of 20 
to 35 years of age after an overnight fast. Blood from each individual 
was collected in a 470 ml plastic vacuum container (Abbott) which con­
tained 2115 U.S.P. units sodium-heparin in saline with sodium citrate as 
buffer. The blood was cooled at 4°C for two hours before centrifugation 
to remove red cells and white cells. Analyses of cholesterol, trigly­
ceride and phospholipid were made on each plasma sample, and only the 
samples with normal lipid levels were pooled and utilized.
Antibodies
Rabbit serums containing antibodies to human whole serum, human 
%)oA-LP, human ApoB-LP, human albumin, and human y-globulin were obtained 
from Hoechst Pharmaceutical Company (Lloyd Brothers, Cincinnati, Ohio). 
Goat serums containing antibodies to rabbit whole serum, rabbit Y-globu- 
lin and rabbit whole globulin were purchased from Mann Laboratory, New 





Disodium salt of EDTA, sodium bromide, sodium barbital, and bo­
ric acid were obtained from Mallinckrodt Chemical Works, New York; Noble 
special agar from Difco, Detroit, Michigan; Amido Black lOB and 99^ cae­
sium chloride from K and K Laboratories, Plainview, New York; sodium 
chloride from Baker, Phillipsburg, N. J.; Ponceau Red and Oil Red 0 from 
Allied Chemical, New York; nigrosin and sodium acetate from Fisher, Fair 
Lawn, N. J.; amino acid calibration mixture, type 1, for amino acid ana­
lyzer from Beckman, Palo Alto, California; glucosamine • HCl and Tris 
from Mann, New York.
Methods
Isolation and Fractionation of LDL 
The isolation procedure, a modification of the method of Lindgren, 
Elliot and Gofman (l9), is outlined in Figure 2. Fresh plaséa was sub­
jected to ultracentrifugation by layering under NaCl solution of density 
1.006 g/ml (8:3 by volume) in Beckman polyallomer tubes (s/S" dia. x 3") 
in the No. 50 rotors of the Spinco Model L or Model L-2 preparative ul­
tracentrifuges at 4°. Lipoproteins of density less than 1.006 g/ml were 
floated at 105,000 g for 22 hours, and the top layer was removed by a 
tube-slicing technique. The bottom portion was collected. A sample was 
dialyzed against a NaCl solution of known density at 4°C until equilib­
rium was reached. The difference in density at equilibrium between di- 
alysate and the sample was considered as the density contributed to the 
salt solution by proteins and lipoproteins. This Ad was taken into con­
sideration each time during actual measuring of the density of a protein
Top^fraction 
d < 1.006 g/ml
Plasma
NaCl solution of d = 1.006 g/ml 
layered on top of plasma 
Centrifugation at 105,000 g. 22 h.
Bottom fraction
Solvent density adjusted to
1.009 g/ml with NaCl 




Solvent density adjusted to 
1.019 g/ml with NaBr 




Solvent density adjusted to 
1.030 g/ml with NaBr 




Solvent density adjusted to 
1.040 g/ml with NaBr 





Solvent density adjusted to
1.053 g/ml with NaBr 




Solvent density adjusted to
1.063 g/ml with NaBr 
Centrifugation at 105,000 g. 22 h.rTop fraction 
d 1.053-1.063 g/ml
Bottom fraction d > 1.063 g/ml 
Figure 2. Ultracentrifugal isolation and fractionation of human plasma low-density lipoproteins.
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or lipoprotein solution for a true solvent density. After adjusting the 
solvent density to 1.009 g/ml with NaCl, the bottom fraction was <b̂ jirri- 
fuged at 105,000 x g for 22 hours. Lipoproteins collected on the top of 
the tubes were designated as d 1.006-1.009 g/ml. Solvent densities of 
the bottom fractions were increased to 1.019, 1.030, 1.040, 1.053 and
1.063 g/ml successively with NaBr and each fraction was centrifuged at 
105,000 X g for 22 hours. The density ranges of the lipoproteins col­
lected from the top of the tubes were designated as 1.009-1.019, 1.019- 
1.030, 1.030-1.040, 1.040-1.053 and 1.053-1.063 g/ml, respectively. Each 
solvent density was determined from infranatant sample by dialysis against 
a salt solution till equilibrium, as described previously. Each subfrac­
tion was washed with NaBr at its upper density for 22 or 48 hours once or 
twice to remove the traces of albumin. The washing procedure yielded 
subfractions free of albumin, as demonstrated by immunochemical analyses.
Purification of LDL 
Ultracentrifugally isolated low density lipoproteins frequently 
contained ApoA-LP, especially at the density range 1.030-1.063 g/ml. 
Washing and repeated centrifugations did not remove completely the ApoA- 
LP. In order to remove the traces of ApoA-LP a procedure for purifying 
LDL with antibodies to human ^oA-LP was developed. Fifteen to twenty- 
five ml of rabbit serum containing antibodies to human ApoA-LP were pool­
ed, solution density was adjusted to 1.250 g/ml with caesium chloride, 
and the mixture was centrifuged at 165,000 g for 44 hours. Rabbit serum 
lipoproteins were removed from the top of the tubes. In the lower por­
tion of the tubes, y-globulin and other lipid-free proteins were collect­
ed and tested for the presence of rabbit y-globulin with goat serum con­
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taining antibodies to rabbit whole serum and/or rabbit total globulin or 
rabbit Y-globulin. Subsequently, a series of test tubes containing dif­
ferent ratios of antigen and antibody, that is, different ratios of LDL 
subfractions containing traces of ApoA-LP and anti-ApoA-LP of density 
greater than 1.25 g/ml were set up. After gently mixing and setting for 
24 hours, they were centrifuged at 840 x g to remove the antigen-antibody 
precipitate. The supernate was tested for the possible presence of ApoA- 
LP with anti-ApoA-LP by double diffusion technique. The traces of ApoA- 
LP were removed by utilizing the optimal ratio of antigen-antibody. Then, 
the density of the mixture was adjusted to the upper density of the orig­
inal fraction and centrifuged at 165,000 g for 44 hours to remove the 
rabbit proteins. The purified ApoB-LP subfractions were collected from 
the top of the centrifuge tubes and used for characterization studies.
Delipidization of ApoB-LP Subfractions
The ApoB-LP subfractions isolated and purified by ultracentrifu­
gation were dialyzed at 4°C against 0.05% EDTA, pH adjusted to 7.0-7.3 
with NaOH, with changes of EDTA solution three times daily until the di- 
alysate was free of chloride and bromide ion. The dialyzed ApoB-LP solu­
tion was subsequently concentrated with 50% dextran 80 solution if the 
protein concentration was below 4 mg per ml.
Total delipidization was carried out according to the following 
procedure: ApoB-LP solution (2-3 ml) was added drop by drop to a 50 ml
glass-stoppered centrifuge tube containing ethanol and peroxide-free di­
ethyl ether (3:1 v/v) which was precooled to -30°C. Care was taken to 
limit the air space. The tube was stoppered and shaken gently and allow­
ed to set at -30°C for two hours. Prior to the separation of the precip­
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itated protein, the tube was shaken for a few minutes and centrifuged at 
840 X 9 for 20 minutes. The organic solvent was decanted. The protein 
was further extracted five times with the same solvents but by rotating 
gently (15-20 rpm) for 30 minutes at 4°C. Extraction was continued in 
the same manner for 16 hours using a mixture of ethanol-diethyl ether 
(1:3, v/v). The protein was then washed 4-5 times with peroxide-free di­
ethyl ether. The tubes containing proteins were covered with aluminum 
foil and placed in an evacuated desiccator overnight at 4°C; the samples 
were stored in a desiccator at room temperature.
In some cases, attempts were made to retain the solubility of 
the delipidized proteins by the following modification of the delipidiza­
tion procedure: the salt-free /^oB-LP solution was concentrated to 15-25
mg protein per ml. Eight to five volumes of ethanol-diethyl ether (3:1 
v/v), precooled to 4°C, were added to one volume of ApoB-LP solution, fol­
lowed by gentle shaking. The mixture was stored for two hours at 4°C, 
and then centrifuged at 840 x g for 15 minutes. The organic solvent was 
decanted. The precipitate was extracted four times with the same solvent 
by gentle shaking at 4°C. Then, it was washed five times with peroxide- 
free diethyl ether at 4°C. The diethyl ether was removed, and the pro­
tein was stored in the same manner as described previously.
Characterization of LDL Subfractions
The LDL subfractions obtained ultracentrifugally were character­
ized by the following techniques: (l) immunodiffusion and immunoelectro-
phoresis, (2) cellulose acetate electrophoresis, (3) starch gel electro­
phoresis, (4) chemical composition of ApoB-LP, (5) analytical ultracen­
trifugation, (6) amino acid composition of protein moiety, and (?) other
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studies on delipidized /^oB-LP.
Immunodiffusion and immunoelectrophoresis. Ouchterlony's (72) 
method of the double diffusion was used as follows: a 1% agar solution
in veronal buffer, pH 8.6, p. 0.1, was prepared by heating the mixture in 
a boiling water bath for 20 minutes followed by cooling to 56°C. The 
solution was then transferred at 56°C to a precleaned, leveled, glass 
plate greased and supported by a plastic frame. The solution was allowed 
to cool and gel at room temperature for four hours. Then it was stored 
in a closed chamber saturated with moisture. The agar plate, when equi­
librated with the moisture after two hours, was ready to use. Wells of 
diameter 3 mm of different arrangements were made with a gel punch (LKB, 
Stockholm, Sweden). They were correspondingly filled with antibodies and 
antigen. The plate was allowed to develop for 24 hours in the closed 
chamber at room temperature. A different pattern was used for immuno­
electrophoresis. A center trough (1.2 x 65 mm) was made with two holes 
(dia. 1 mm) on each side of it. The two holes were filled with antigens. 
Electrophoresis was performed at a constant voltage (7 volts per cm) in 
a veronal buffer, pH 8.6, p. 0.1, for 90 minutes. Upon finishing the 
electrophoresis, an antibody or a mixture of antibodies were added to the 
center trough. The reaction was allowed to develop for 24 hours at room 
temperature. For staining the patterns, the agar plate was first washed 
with saline to remove the excess proteins or lipoproteins, then washed 
with distilled water to remove salts followed by drying with filter paper 
and stained either with Amido Black lOB for protein or with Red Oil 0 
for lipid at 37°C.
Cellulose acetate electrophoresis. Two different apparatuses
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were used. One was the Cplab Tank surrounded with the cooling system.
Two hundred volts were applied for 2-3 hrs to eight 3 x 14 cm strips of 
cellulose acetate in Michaelis buffer of pH 8.6, p, 0.15. Either 0.2% 
Ponceau Red in 3% TCA or 0.001% nigrosin in 2% acetic acid was used for 
staining. Another apparatus, Beckman Microzone Cell Model R-101, was 
also used. Here, eight micro samples were applied on one piece of cel­
lulose acetate (5.5 x 14 cm). Electrophoresis was performed at constant 
voltage (250 volts) in veronal buffer, pH 8.6, p 0.075, for 45-55 minutes 
at room temperature. The cellulose acetate strips were stained with 
Ponceau Red.
Starch gel electrophoresis. The starch gel was prepared accord­
ing to the procedure of Smithies (115). Hydrolyzed starch was molded 
(l X  14 X  15 cm) in Tris buffer, pH 8.6, j. 0.075, and allowed to set over­
night. Samples were applied on small pieces of filter paper (Whatman No. 
l) and placed in a slit in the gel 3 cm from the cathode end. Borate 
buffer, pH 8.2-8.6, was used as buffer in the electrode vessels. The 
electrophoresis was conducted with a potential gradient 6 v/cm for 16 
hours at room temperature. The gel was then stained with Amido Black lOB.
Chemical composition of ApoB-LP. ApoB-LP subfractions were sub­
jected to lipid and protein analysis. Samples for both determinations 
were aliquoted simultaneously. Protein was determined according to the 
method by Lowry et (116). Where a sufficient quantity of sample was 
available, nitrogen content was also determined by the method of Kjeldahl 
(117). Protein content determined by latter method was estimated by sub­
tracting lipid nitrogen from total nitrogen and multiplying by the factor 
6.25 as shown in the following formula (48):
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6.25(N-Px^) [l]
where N = concentration of nitrogen in mg per ml
P = concentration of lipid phosphorus in mg per ml
Aliquots for lipid determinations were extracted successively 
with chloroform-methanol (2:1, v/v), acetone-ethanol (1:1, v/v), ethanol- 
diethyl ether (3:1, v/v), and diethyl ether. Aliquots for the determina­
tion of free and total cholesterol, phospholipids, triglycerides and free 
fatty acids were taken in duplicate, and each was evaporated to dryness 
prior to redissolving in appropriate solvents. Total and free cholesterol 
were determined by the modified method of Schoenheimer and Sperry (118); 
cholesterol esters were estimated as cholesterol linoleate. Triglycer­
ides were determined by the method of Van Handel and Zilversmit (119), 
free fatty acids by the modified method of Dole (l20), and lipid phos­
phorus by the method of Fiske and Subbarow (121). A factor of 25 was used 
to convert the lipid phosphorus to phospholipid.
Analytical ultracentrifugation. Sedimentation, flotation and 
diffusion coefficients on each ApoB-LP subfraction were measured in a 
Spinco Model E analytical ultracentrifuge equipped with a schlieren opti­
cal system and RTIC unit for indicating and regulating temperature. All 
experiments were carried out at 25°C. Whereas sedimentation and flota­
tion experiments were performed generally at rotor speed of 52,640 rpm 
and only occasionally at 56,100 rpm, 59,780 rpm, 47,660 rpm, or 42,040 
rpm, the diffusion experiments were carried out at 12,590 rpm. Photo­
graphs of the schlieren patterns were taken by the automatic mechanism of
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the ultracentrifuge. Usually 10 pictures were taken for each experiment. 
A Nippon Kogaku KK Shadowgraph Model 6 which gave an accuracy of 0.0001 
cm was used to magnify and measure the plates.
Samples of 3-4 ml were equilibrated with a NaCl solution of 
known density containing 0.01% EDTA, pH 6.8-7.0, by dialyzing the samples 
against it for 32-40 hours with three changes of external solution daily.
Specific gravity of each solvent was measured at 25°C by hydro­
meter (Fisher) which was calibrated against water at 15°C. The density
of each solvent at 25°C was calculated from the value of specific gravity
multiplied by 0.9991, the density of water at 15°C.
Viscosity of solvents was measured with an Ostwald viscometer 
and calculated by equation [2] (122)
n = Apt - B(p/t) [2]
where p is the density of solvent and t is the time of flow in seconds.
A and B are constants determined by two solutions of known viscosity val­
ues. Distilled water and 0.15 M NaCl were used as references. Viscosity 
values of NaCl solutions were taken from International Critical Tables. 
All experiments were carried out in a constant temperature water bath 
(Circu-Temp Chemical Rubber Co.) maintained at 25° + 0.1°C.
Determination of sedimentation and flotation coefficients. The 
sedimentation coefficient, S, was calculated according to Svedberg and 
Katsurai (123) by using the following equation:
5 _ dx / dt Qj. d In X / dt [3]
tiî X
where x is the distance in cm from boundary to the center of rotation at
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time t (in seconds) and w is the angular velocity of centrifugation in 
radians per second. The flotation coefficient, S f ,  was calculated by the 
same equation, but it contains a negative slope, d In x / dt.
A Fortran computer program (see Appendix B) was written to give 
the values of log x in parallel with In x from the data measured from, 
schlieren patterns. The slope d log x / dt (or d In x / dt) was obtained 
by plotting log x (or In x) values against time t.
Three to four different lipoprotein concentrations were used for 
each determination. The flotation and sedimentation coefficients at in­
finite dilution, Sf  and S°, were obtained by extrapolating the S f -  and 
S-values at three different protein concentrations.
The observed S value was corrected to SgQ^^» sedimentation 
coefficient in water at 20°C, according to Svedberg and Pedersen (124), 
and expressed in seconds or in Svedberg units (l S = 10"^^ cgs. units).
where = viscosity of solvent at t°C
n° = viscosity of water at t°C
hgo = viscosity of water at 20°C
= partial specific volume of solute in the investigated solvent 
at t°C
VgQ = partial specific volume of solute in the same solvent at 20Sé 
Pf = density of solvent at t°C 
PgQ = density of water at 20°C 
was determined experimentally at 25°C (see hydrated density). VgQ was
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calculated from by assuming the temperature variation of the partial
specific volume of ApoB-LP to be similar to that of other common proteins 
(125). The sedimentation coefficient at 25°, was obtained by ex­
trapolating the S and Ŝp to 0.9971 g/ml, density of water at 25°C. This 
extrapolated could be checked by equation [5].
=25,» = 2̂5 1 - VfPt
where n°^ = viscosity of water at 25°C 
Pg5 = density of water at 25°C
The standard flotation coefficient gg at 26°C in a NaCl solu­
tion of density 1.063 g/ml should be calculated from that at 25°C, Sf^25> 
theoretically according to equation [ô]
4.26 = 4,26 L6]
'̂ 26/̂ 20 ’̂25 ’̂26 “ ^25 25
where ^25/̂ 2̂0 '̂ 26/'̂ 20 are the viscosities of water at 25°C and 26°C
relative to that at 20°C. Assuming that the variations of the viscosity
and density of the solvent as well as the change in partial sepcific vol-
0 0ume of ApoB-LP from 25 to 26 are negligible, the difference between 
Sf 2̂5 and Sf^26 would be very small.
Hydrated density determination. Four to five flotation and/or 
sedimentation determinations were performed on same sample at different 
solvent densities. The observed S's and S^'s multiplied by the viscosity 
of each solvent were a linear function of solvent density. The density 
at which the solute had a zero sedimentation rate was defined as the hy­
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drated density of the solute.
Calculation of partial specific volume. Since sedimentation 
coefficient is proportional to (l - Vp) as shown by equation [v]
S = M(.l - Vp). [7]
Nf
where M is the molecular weight, N is the Avogadro's number and f is the 
frictional factor, S, V and p have the same meaning as previously de­
scribed.
If S = 0,
1 -  Vp = 0
Then, V = 1 [s]
P
Therefore, the reciprocal value of the hydrated density is the partial 
specific volume of the lipoprotein.
Diffusion coefficient determination. Diffusion experiments were 
performed according to the procedure described by Schachman (126) with a 
synthetic boundary cell. The apparent diffusion coefficient, D^pp, was 
calculated from schlieren patterns according to equation [9]
Dapp “ 4rt
where A is the area in cm^ between the gradient curve and the baseline 
at time t measured from the instant when the synthetic boundary was form­
ed, and the maximum height of that curve. F is the magnification
along the baseline, t is the time in seconds, and m is the angular veloc­
ity of the centrifugation in radian per second. The factor (l - w^st)
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was introduced by Lamm (l27) in order to correct for the influence of the 
variation of the centrifugal field in the different parts of the diffus­
ing boundary. The area was measured through the ordinates of the grad­
ient curve at a definite interval. For the purpose of time saving a 
Fortran computer program (see Appendix B) was developed for the calcula­
tion of the area A and the Ci__. The D___ was calculated usually forapp app
4-8 pictures taken at different times. The values of D^pp showed a slight 
time dependence because the initial boundary was not infinitely sharp. 
"Zero time correction" was made from a plot,of the D^pp versus the recip­
rocal of time. The intercept of this linear plot at l/^ = 0, correspond­
ing to infinite time, is the true diffusion coefficient for zero time. 
Diffusion coefficients at infinite dilution, D°pp, were extrapolated from 
Dgpp values obtained at two to three different lipoprotein concentrations. 
Dgpp was then further corrected to the diffusion coefficient, ac­
cording to the standard (126) equation [lO]
00 o oQo n+ n+
^20, w = Dapp ( 273+t ̂ ̂ 70^ ( ZÔ" ) LlO]
't '20
where t is temperature in centigrade and n's are as defined in equation 
[4].
Molecular weight calculations. Molecular weights were calcu­
lated from sedimentation velocity and diffusion coefficient according to 
the Svedberg equations:
where R is the gas constant, 8.314 x 10^ erg/mole/degree, T is the abso­
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lute temperature, °K, at which the S and D values were determined, V and 
p are the partial specific volume of the solute and the density of the 
solvent at the temperature T. S is expressed in seconds.
Amino acid analysis. Three to four mg of delipidized lipopro­
tein (Apolipoprotein B) of each subfraction was hydrolyzed with 1 ml 5.7 
N glass distilled HCl in an evacuated, sealed tube at 110® + 1®C for 24
hours. One of the samples was also hydrolyzed for 72 hours in order to
determine the percentage of destruction during hydrolysis. The hydroly­
sates were dried in a rotary evaporator at 37®C, redissolved in distilled 
water, and evaporation was repeated. The residues were then dissolved in 
3 ml of 0.2 N Na-citrate buffer, pH 2.2. Aliquots were analyzed in trip­
licate by ion exchange chromatography with a Beckman Model 120 C amino 
acid analyzer. The neutral and acidic amino acids were chromatographed 
on a 50 cm "long" column containing Beckman PA 28 resin and eluted with
citrate buffer, pH 3.28, first for 85 minutes, and followed then with the
same buffer, pH 4.25, for 105 minutes. The basic amino acids were placed 
on a 6 cm "short" column packed with Beckman resin PA 35 and eluted with 
citrate buffer, pH 5.25, for 57 minutes. - -
The analyzer was calibrated with the type 1 amino acid calibra­
tion mixture and, in studies of the performic acid-oxidized protein, with 
the oxidized calibration mixture and cysteic acid.
Half-cystine and methionine were determined as cysteic acid and 
methionine sulfoxide after oxidizing the apolipoprotein B with performic 
acid. The values for cysteic acid were corrected for the 94% recovery 
found by Moore (l28).
Tryptophan was determined spectrophotometrically by the method
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of Spies and Chambers (l29) with the p-dimethylaminobenzaldehyde-HgSO^ 
reagent.
Glucosamine was determined on a separate hydrolysate with the 
amino acid analyzer. Glucosamine • HCl standard and the samples were hy­
drolyzed in 2 N HCl at 110° + 1°C for 16 hours. Hydrochloric acid was re­
moved and the hydro.lysates were redissolved in the citrate buffer as pre­
viously described. After filtration, the hydrolysates were chromatograph­
ed on the short column and eluted in the same manner as described already 
for basic amino acids.
The amino acid analysis of HCl-hydrolysates of ApoB-LP subfrac­
tions revealed on several occasions the presence of a small peak at the 
position assigned usually to cysteic acid (17 minutes), and indicated thus 
the possible presence of another compound at this position. The apolipo­
protein B was extracted exhaustively with chloroform-methanol (2:1, v/v) 
and the extract was subjected to phosphorus determination by the micro­
method of Gerlach and Deuticke (130); even the application of this highly 
sensitive method failed to detect the presence of phosphorus in the ex­
tract. Subsequently, the apolipoprotein B dissolved in the 0.018 N sod­
ium hydroxide was precipitated by 10% trichloroacetic acid and sedimented 
by low speed centrifugation. The phosphorus determination of a non-di- 
gested aliquot of supernate showed the absence of inorganic phosphorus 
and that of a digested aliquot the presence of organic phosphorus. Al­
though the occurrence of a small amount of non-extractable phospholipid 
could not be ruled out, it was thought necessary to test apolipoprotein 
B for the possible presence of phosphoserine. A reference sample of phos- 
phoserine (Calbiochem, Los Angeles, Calif.) dissolved in citrate buffer.
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pH 2.2, was chromatographed on the long column in the Beckman Model 120 C 
amino acid analyzer. The phosphoserine peak overlapped with that of 
cysteic acid (17 minutes). Qualitative determination of phosphoserine 
was performed by the following procedure. Apolipoprotein B samples were 
hydrolyzed in 5.7 N HCl in open tube for one hour at 100°. The HCl was 
removed by evaporating the hydrolysate to dryness over NaOH in vacuo. The 
residue was redissolved in distilled water and the solution was subjected 
to high voltage electrophoresis in the Vanguard Model 905 apparatus. 
Cysteic acid and phosphoserine were used as the reference compounds. The 
l^ydrolysate was applied to Whatman No. 1 paper and the electrophoresis 
was performed with a buffer system composed of pyridine-acetic acid-water 
(1:10:289, v/v/v), pH 3.6, for 50 minutes at 3000 volts. The papers were 
stained with 0.05% ninhydrin in ethanol and the color was developed by 
heating the papers in oven at 100°.
Other studies of delipidized ApoB-LP subfractions. Attempts 
were made to solubilize the apolipoprotein B without any additives. It 
was found that the apolipoprotein obtained by delipidization of ApoB-LP 
under mild condition (as described in delipidization procedure) would 
dissolve in Tris buffer, pH 8.3, p 0.1, and in 0.018 N sodium hydroxide 
at room temperature. A further increase in the solubility of apolipo­
protein B could be achieved by heating the sample for 30 minutes at 37°; 
the protein could be dissolved almost completely by heating it slowly in 
a sand bath for 30 minutes at 70-75°. The proteins obtained by vigorous 
delipidization (as described previously) would dissolve only slightly in 
Tris buffer, but would dissolve almost completely in dilute sodium hy­
droxide, pH 12, after heating at 70-75°C. Immunochemical properties of
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these ApoB solutions were studied by immunodiffusion technique with rabbit 
sera containing antibodies to human /^oB-LP, human ApoA-LP and human albu­
min. Sedimentation and diffusion coefficients were determined at 2-3 dif­
ferent protein concentrations at pH 8.3 and pH 12 with and without heat­
ing. Also, one sample was determined at pH 7.0, obtained from pH 12 so­
lution by adding HCl. Cellulose acetate electrophoresis was performed on 




Isolation and Fractionation of LDL 
Low-density lipoproteins were isolated from plasma of fasting 
healthy human donors by sequential preparative ultracentrifugation. Very 
low-density lipoproteins were first isolated by layering plasma under 
NaCl solution of density 1.006 g/ml and removing the material which 
floated at the top of the ultracentrifuge tubes. The solvent density 
(excluding the density of lipoproteins and proteins) of the bottom frac­
tions was successively increased to 1.009, 1.019, 1.030, 1.040, 1.053 and
1.063 g/ml. It was found that the density contributed by proteins and
lipoproteins was usually 0.010 to 0.013 g/ml depending on the concentra­
tion of the protein in the remaining plasma. The six lipoprotein frac­
tions collected from the tops of the tubes were designated according to 
the solvent density at which they were isolated: (l) Fraction 1 (1.006-
1.009 g/ml); (2) Fraction 11 (1.009-1.019 g/ml); (3) Fraction 111 (1.019-
1.030 g/ml); (4) Fraction IV (1.030-1.040 g/ml); (5) Fraction V (1.040-
1.053 g/ml); and (6) Fraction VI (1.053-1.063 g/ml). It was realized, 
however, that the true densities of the lipoproteins floating at the tops 
of the tubes were considerably less than the original densities of the 




The purity of the LDL fractions was determined by standard pro­




Immunodiffusion. All six subfractions of low-density lipopro­
teins isolated ultracentrifugally gave identical precipitin lines against 
rabbit serum containing antibodies to human ApoB-LP using Ouchterlony's 
technique of double diffusion. Results are shown in Figure 3. At low 
antigen concentration only a single precipitin line was usually observed. 
But, at higher antigen concentration two and, occasionally, three precip­
itin lines were found in the same sample. This is illustrated in Figure 
4.
The isolated LDL fractions were usually contaminated with albu­
min as detected by immunological tests. However, this contamination could 
be eliminated by recentrifugations. No y-globulin contamination has ever 
been observed (Figures 5 and 6). However, the”presence of apolipoprotein 
A-containing lipoprotein (ApoA-LP) was observed in practically all frac­
tions at one time or another. In the upper density ranges such as 1.030-
1.063 g/ml, Apok-L? has been detected constantly (Figure 7). Washing and 
repeated centrifugation of the lipoprotein could not completely remove the 
ApoA-LP as demonstrated in Figure 8 where both the unwashed and the washed 
LDL fractions gave reactions with rabbit serum containing antibodies to 
human ApoA-LP. This reaction was nonidentical to the antigen-antibody re-
I Figure 3. Immunological identity of
six LDL subfractions.
Center well: rabbit serum containing
anti-human ApoB-LP. A to F: LDL Fractions I
to VI, characterized by densities 1.006 to 1.063 
g/ml.
Figure 4. Multiple precipitin lines 
observed in antigen-antibody reaction.
Center well: rabbit serum containing
anti-human ApoB-LP. A and C: LDL (1.009-1.063
g/ml). B and D: LDL (1.009-1.019 g/ml). Note
three precipitin lines in D but only two in B.
Figure 5. Contamination by albumin ob­
served in LDL before washing.
Center wells : left, rabbit serum con­
taining anti-human albumin; right, anti-human y- 
globulin. A: human albumin; B and D: LDL frac­
tions before washing; C: human serum.
Figure 6. Contamination by albumin 
eliminated in LDL after washing.
Same arrangement of antigens and anti­




Presence of i\poA-LP in the
Center well: rabbit serum containing
anti-human ̂ wA-LP. A: Human ̂ x̂iA-LP; B to F:
LDL Fractions I + II, III, IV, V and VI, respec­
tively. Note that the precipitin lines at C, D, 
E and F are identical to A (î xjA-LP).
Figure 8. Washing and recentrifuga­
tion of LDL Fractions IV and V.
Center well: rabbit serum containing
anti-human ApoA-LP. A and B: LDL Fraction IV
after washing; C and D: LDL Fraction V after
washing.
Figjnre 9. Interaction between human LDL and rabbit sera containing antibodies to human ApoA- 
LP and to human i^B-LP.
Center well: LDL. A and C: rabbit serum containing antibodies to human ApoA-LP; B and D:
rabbit serua ccmtaining antibodies to human ApoB-LP. Note the identity reaction between A and C, B and 
D, and the nonidentity reaction between A and B, and C and D.
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action with anti-human ApoB-LP indicated by the crossing of the two pre­
cipitin lines (Figure 9). This crossing indicated also that the reaction 
with anti-ApoA-LP was not due to contamination of that antiserum with 
anti-ApoB-LP. In addition, it was demonstrated that anti-ApoB-LP did not 
give a precipitin reaction with ApoA-LP. Therefore, all precipitin lines 
obtained with anti-ApoB-LP must be due to the presence of /^oB-LP.
Removal of ApoA-LP from the LDL subfractions was accomplished 
by precipitation with the y-globulin fraction of rabbit serum containing 
antibodies to human ApoA-LP. Each step of the procedure was followed 
closely by immunodiffusion. As the concentration of ApoA-LP in an LDL 
sample was reduced, the corresponding immunological precipitin line moved 
closer to the antigen-containing well. When the precipitin line disap­
peared, the degree of purity was considered satisfactory. The results of 
this stepwise purification procedure are shown in Figures 10 and 11.
After precipitating ApoA-LP by anti-human ApoA-LP, the added 
foreign rabbit proteins were removed from the LDL solutions by ultracen­
trifugation during which they sedimented to the bottom of the tubes. The 
top portions of the tubes contained the lipoproteins free of rabbit pro­
teins. Removal of rabbit proteins was checked by immunodiffusion util­
izing goat serum containing antibodies to rabbit y-globulin and rabbit 
total globulin as shown in Figure 12. It was noticed that human albumin 
had been added to the commercial preparations of rabbit serum containing 
antibodies to human ApoA-LP. Fortunately, it was found that the added 
human albumin was removed simultaneously with rabbit proteins by ultracen­
trifugation (Figure 13). The purified LDL fractions are now called ApoB- 
LP in order to distinguish them from the immunochemically-heterogeneous
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Figure 10. Stepwise purification of LDL
Center wells: rabbit serum containing antibodies to human ApoA-
LP. A: LDL before purification; B, C: LDL under purification; D: LDL
purified. Note that the precipitin lines are closer to B and C than to 
A, and disappear at D indicating the removal of ApoA-LP.
Figure 11. Comparison of LDL before and after precipitation of 
ApoA-LP by anti-human ApoA-LP.
Center well: rabbit serum containing antibodies to human ApoA-
LP. A and D: human ApoA-LP; C and E: LDL before purification; B and
F: LDL after purification—
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Figure 12. Testing for the presence 
of rabbit proteins in purified LDL fractions.
Center wells: top - goat serum con­
taining antibodies to rabbit yglobulin; bot­
tom - anti-rabbit total globulin. A, B: sam­
ples from top portion of centrifuge tubes of 
purified LDL Fraction III; C: sangle from top 
portion of LDL Fraction IV; D: sample from 
bottom portion of centrifuge tubes of LDL Frac­
tion IV.
Figure 13. Testing for the presence of human albumin in puri­
fied LDL fractions.
Center well: rabbit serum containing antibodies to human albu­
min. A to E: the purified LDL Fractions I + II, III, IV, V and VI, re­
spectively. F: human albumin.
Figure 14. Comparison of the immunochemical properties of LDL 
fractions before and after purification.
Center trough: rabbit serum containing antibodies to ApoB-LP.
A, B, C, D (bottom row): samples from LDL Fractions II to V before puri­
fication. A, B, C, D (top row) : samples from corresponding Fractions 
after purification.
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LDL. The purified ApoB-LP subfractions were still reactive to anti-human 
ApoB-LP as demonstrated in Figure 14.
Immunoelectrophoresis. All subfractions with the exception of 
Fraction I (1.006-1.009 g/ml) were submitted to immunoelectrophoresis. 
There was practically no difference among the patterns obtained with each 
ApoB-LP subfraction and rabbit serum containing antibodies to human ApoB- 
LP or human VLDL. A single precipitin line with or without tailing from 
the origin appeared at a position behind albumin and ApoA-LP but over­
lapping partially with the reaction given by /^oA-LP. When the center 
trough contained anti-human whole serum mixed with anti-human ApoA-LP and 
anti-human albumin, the purified LDL subfractions showed none of the pre­
cipitin lines characteristic of ^oA-LP or albumin. Some typical pat­
terns are shown in Figures 15, 16, 17, 18 and 19. However, even before 
purification, the presence of ApoA-LP which was demonstrated clearly by 
immunodiffusion could not be detected by this method. Therefore, immuno­
electrophoresis has been used throughout this study only as a method of 
characterization, but not as a criterion of purity. _ _
Cellulose Acetate Electrophoresis 
By cellulose acetate electrophoresis each ApoB-LP subfraction 
showed a single band, close to the origin if the sample was applied be­
tween anode and cathode, and migrated toward anode at the position of p- 
globulin if applied near the cathode. Prior to the purification of sub­
fractions, albumin was also detectable whereas ApoA-LP was not.
Starch Gel Electrophoresis 
Each /^oB-LP subfraction exhibited a single band on starch gel
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Figure 15. Immunoelectrophoresis of human whole serum and ApoB- 
LP Fraction II.
Center trough: mixture of rabbit sera containing antibodies to
human serum, human ApoB-LP, and human VLDL. A: human whole serum; B: 
purified ApoB-LP Fraction II.
Figure 16. Immunoelectrophoresis of ApoB-LP fractions.
Center trough: rabbit serum containing antibodies to human
ApoB-LP. A: Fraction III; B: Fraction V.
Figure 17. Immunoelectrophoresis of ApoB-LP fractions.
Center trough: rabbit serum containing antibodies to human
VLDL. A: Fraction III; B: Fraction V.
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Figure 18. Immunoelectrophoresis of ApoB-LP and human albumin.
Center trough: mixture of rabbit sera containing antibody to 
human serum, human ApoA-LP, and human albumin. A: ApoB-LP (1.009-1.053 
g/ml); B: human albumin.
Figure 19. Immunoelectrophoresis of ApoB-LP and ApoA-LP.
Center trough: mixture of rabbit sera containing antibodies to 
human serum, human ApoA-LP, and human albumin. A: ApoA-LP; B: ApoB-LP 
(1.019-1.030 g/ml). Note absence of ApoA-LP in ApoB-LP Fraction.
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electropherograms. The bands migrated toward the anode. There was no 
significant difference among the mobilities of various subfractions. A 
typical pattern of starch gel electrophoresis of ApoB-LP subfractions is 
shown in Figure 20.
Chemical Composition of ApoB-LP Subfractions 
Determinations of free cholesterol, cholesterol ester, trigly­
ceride, phospholipid, and protein were performed on each /^oB-LP subfrac­
tion. The results are presented in Table 5. Six such analyses were done 
on each of Fractions IV and V; for these standard deviations are included. 
The results of analysis of Fraction II were not satisfactory due to the 
extremely small amount of material available, and therefore have not been 
included in the table. Since all figures represent an average value of 
several determinations the totals for each subfraction are not necessar­
ily equal to one hundred percent. Triglyceride content was the most vari­
able, as would be expected from its close dependence on sex, age, dietary 
habits and fasting interval of the donors.
Cholesterol ester increases slightly with increasing density 
while free cholesterol remains fairly constant in all subfractions. Tri­
glyceride decreases drastically with increasing density. Both phospho­
lipid and protein content are constant from Fraction III through Fraction 
VI. They are lower in Fraction I, but the phospholipid/protein ratio is 
the same for all fractions including Fraction I. The neutral lipid/(phos- 
pholipid + protein) ratio for Fraction I is 1.9; for Fractions III through 
VI it is close to a constant value of 1.18.
Free fatty acid values were not included in the table. However, 
the fatty acids of Fractions IV and V were determinedÿ the weight percent-
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tions.
Figure 20. Starch gel electrophoresis of purified ApoB-LP Frac-
A: Fraction V; B: Fraction III; C: Fraction IV; D: Fraction 
II, and E: vdiole serum. Stained for protein. Origin at lower edge. 
ApoB-LP band migrated slower than g-globulin in the sanq)le of \diole serum.
TABLE 5
PERCENT CHEMICAL COMPOSITION OF HUMAN PLASMA ApoB-LP SUBFRACTIONS
Fraction Density Range g/ml CE FC TG PL PR pl/pr N.L./PL-PR
I 1.006-1.009 24.9 7.2 30.4 15.7 17.2 0.97 1.90
II 1.009-1.019 - - - - - - -
III 1.019-1.030 34.97 7.55 8.75 23.13 24.00 0.96 1.09
IV 1.030-1.040 41.30+1.48 6.70+.42 6.35+1.71 21.60+1.86 22.60+1.56 0.96 1.23
V 1.040-1.053 40.64+3.49 7.41+.73 5.60+2.32 21.60+2.09 24.35+2.40 0.89 1.16
VI 1.053-1.063 44.30 6.05 3.78 21.60 22.9 0.98 1.23
CE = Cholesterol ester expressed in terms of cholesterol-linoleate = 1.68 (Total cholesterol- 
Free cholesterol).




N.L. = Neutral lipid = CE + FC -t TG.
CJio
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ages were 1.8 and 1.4, respectively.
Physical-Chemical Characterization 
of ApoB-LP Subtractions
Determination of sedimentation and flotation coefficients. Qual­
itatively, all LDL fractions isolated and purified by preparative ultra­
centrifugation gave a single symmetric peak in the analytical ultracentri­
fuge. An asymmetric peak, indicating contamination by ApoA-LP, appeared 
only when the total lipoprotein concentration of a sample was very low.
For this reason, the analytical ultracentrifugation was used only for 
ApoB-LP subfractions which showed no detectable /^oA-LP by immunodiffusion 
tests. All fractions characterized by analytical ultracentrifugation sat­
isfied this criterion except Fraction VI, which contained a relatively 
high concentration of ApoA-LP. Precipitation of ApoA-LP with the y-glob- 
ulin fraction of rabbit anti-ApoA-LP serum removed the major part of im­
purities, but traces of ^oA-LP did remain in this subfraction. Sedimen­
tation and flotation coefficients of every ApoB-LP subfraction were de­
termined at various solvent densities. Figure 21 shows a graph of the 
slope d In x/dt for ApoB-LP Fraction I in a solvent density of 1.063 g/ml, 
centrifuged at rotor speed 42,040 rpm. The Sf value was calculated from
the slope d In x/dt according to equation [s]. Figures 22, 23, 24, 25,
26 and 27 are representative graphs for determination of flotation coef­
ficients of /^oB-LP subfractions. Included are determinations for Frac­
tions I + II, II, III, IV, V and VI in various solvent densities at a
rotor speed of 52,640 rpm. The majority of points fall on straight lines
indicating the reliability of the runs. Some typical ultracentrifugal 












160 4 8 12 20 24 28
TIME iri minutes
Fi^re 21. Determination of S£ of ApoB-LP Fraction I, 1.006-
1.009 g/ml in solvent density 1.063 g/ml. Measurements were taken after
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Figure 22. Determination of Sf of ApoB-LP Fracf on (Ï eru! II),
1.006-1,019 g/ml in solvent density 1.0770 g/ml. MeisuTLi/jnfs were taken
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Figure 23. Determination of Sf of ApoB-LP Fraction II, 1.009-
1.019 g/ml in solvent density 1.0772 g/ml. Measurements were taken after











Fi^re 24. Determination of Sf of ApoB-LP Fraction III, 1.019-
1.030 g/ml in solvent density 1.063 g/ml. Measurements were taken after
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Fi^re 25. Deteimination of Sf of ApoB-LP Fraction IV, 1.030-
1.040 g/ml in solvent density 1.0480 g/ml. Measurements were taken after
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Fi^re 26. Determination of Sf of ApoB-LP Fraction V, 1.040-
1.053 g/ml in solvent density 1.063 g/ml. Measurements were taken after












Figure 27. Determination of Sf of ApoB-LP Fraction VI, 1.053- 
1.063 g/ml in solvent density 1.063 g/ml. Measurements were taken after 
rotor speed reached 52,640 rpm.
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B
Figure 28. Ultracentrifugal flotation patterns of ApoB-LP Frac­
tions I (A), I + II (B), II (C), and III (D).
Experimental conditions: rotor speeds 42,040 rpm (A) and 52,640 
rpm (B, C, D); solvent density 1.063 g/ml; tenperature 25°C. Pictures 




Figure 29. Ultracentrifugal flotation patterns of ApoB-LP Frac­
tions IV (A), V (B), and VI (C).
Experimental conditions: rotor speed 52,640 rpm; solvent den­
sity 1.063 g/ml (A, B) and 1.077 g/ml (C); temperature 25*C. Pictures 
were taken from left to right at 4-minute intervals after rotor reached 
full speed.
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Sedimentation experiments were performed by the same principle. 
Figures 30 and 31 are representative graphs for the determination of sed­
imentation coefficients of ApoB-LP Fractions V and VI at solvent density 
1.0028 g/ml and 1.0052 g/ml, respectively. Again, all points fall on 
straight lines. Schlieren patterns of sedimentation experiments are shown 
in Figure 32.
Both flotation and sedimentation coefficients are concentration 
dependent. Figure 33 shows the determination of flotation coefficients 
at infinite dilution for ApoB-LP Fraction II, 1.009-1.019 g/ml, and ApoB- 
LP Fraction III, 1.019-1.030 g/ml. The flotation coefficients, Ŝ , for 
Fraction II and Fraction III were 16.78 and 12.48, respectively. The 
slopes of 8f versus concentration for both fractions are not identical, 
but are both positive. This indicates that there are no aggregation or 
association phenomena observed at higher ApoB-LP concentrations. Figure 
34 illustrates the determination of the sedimentation coefficient at in­
finite dilution of ApoB-LP Fraction V, 1.040-1.053 g/ml. Four out of five 
points lie on a straight line obtained by plotting the 8-values versus 
lipoprotein concentration. The 8-values also increase with decreasing 
concentration. Again, this suggests that no aggregation or association 
occurs at higher ApoB-LP concentrations. Figure 35 shows the determina­
tion of 8° of ApoB-LP Fraction VI, 1.053-1.063 g/ml. This subfraction 
has also a positive slope.
Values of were calculated according to equation [4] from
the values of the observed sedimentation coefficients (Sq^s.)* Both 
820,w 8f values for each subfraction are presented together with 
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Figure 30. Determination of S of ApoB-LP Fraction V, 1.040-1.053 g/ml in solvent density 
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Fi^re 31. Determination of S of ApoB-LP Fraction VI, 1.053-
1.063 g/ml in solvent density 1.0052 g/ml. Measurements were taken after 
the rotor speed reached 52,640 rpn.
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Figure 32. Ultracentrifugal sedimentation patterns of ApoB-LP 
Fractions II (A, top), III (A, bottom), IV (B), V (C), and VI (D).
Experimental conditions: rotor speed 52,640 ipm; solvent den­
sity 1.003 g/ml (A, B, C), 1.005 g/ml (D); temperature 25°C. Pictures 
were taken from left to ri^t at 0, 4, 8, 16 and 24 minutes (A) and 4- 
minute intervals (B, C, D) after rotor attained full speed.
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Figure 33. Determination of S9 of ApoB-LP Fractions II, 1.009- 
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Hydrated density determinations. Usually, two or three prepara­
tions of each ApoB-LP subtraction obtained on different occasions were
used independently for the determination of hydrated densities. Each 
sample was subjected to three to six flotation and/or sedimentation de­
terminations at different solvent densities. The solvent density at 
which zero sedimentation occurs represents the hydrated density of the 
subfraction. Figure 36 shows the determination of hydrated densities of 
two different preparations of ApoB-LP Fraction I, 1.006-1.009 g/ml. One 
was isolated from the plasma of a male donor, the other was from a female 
subject. It is observed that the hydrated density values are different 
for the two preparations. Although both preparations were isolated at 
the same solvent density range of 1.006-1.009 g/ml, the preparation from
the male donor had a value of 0.9993 g/ml, and that from female donor had
a value of 1.0016 g/ml. Both hydrated density values are considerably 
lower than the density used for the isolation of subfraction. This sub­
fraction would actually represent a subfraction of VLDL, if a hydrated 
density of 1.006 g/ml represents a boundary line between VLDL and LDL as 
suggested originally by Lindgren et (l9).
The different values of S and S f  obtained at the same solvent 
density for these two preparations can be explained mainly by the differ­
ences in distribution of the lipoproteins between the sexes at this den­
sity range. Differences in concentration of the lipoprotein samples may 
also play a small role, since the S and S f values shown on the graph are 
not values obtained at infinite dilution. However, the concentration of 
lipoproteins would not affect the hydrated density value. Altered con-
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TABLE 6
PHYSICAL CHEMICAL CHARACTERIZATION OF HUMAN PLASMA 
























PHYSICAL CHEMICAL CHARACTERIZATION OF HUMAN PLASMA 
ApoB-LP FRACTIONS (l + II), 1.006-1.019 g/ml
Sex
of *25,w *20, w Sf 0
Donors  ̂ xlOl3 cgs xlO^^ cqs A
d .. Son „ c° Diameter
g
M, F 1.0030 1.80 2.96 19.05 244
TABLE 8
PHYSICAL CHEMICAL CHARACTERIZATION OF HUMAN PLASMA












X c  





in  CO 


























































15.75 1.93® 1.68® 244 4.70













IV M 1.0055 2.75 4.24 11/2
14.71
15.90
2.17 17.09 2.18® 1.90® 238 4.58
^Value obtained from a single LP concentration.
TABLE 9
PHYSICAL CHEMICAL CHARACTERIZATION OF HUMAN PLASMA
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1 9 . 2 8 2 . 2
I M, F 1 . 0 1 9 5 . 7 5 5 . 3 0 ® 2/3
1 / 3
1
1 0 . 1 2
1 0 . 3 2
1 1 . 7 8 2 . 0
1 1 . 0 2 . 2 4 ® 1 . 9 5 ® 2 1 7 3 . 2 6
II M, F 1 . 0 1 8 6 . 5 0 5 . 97B
Î /
1 2 . 0 8
1 2 . 1 8 -
1 2 . 3 9 2 . 0 5 ® 1 . 7 9 ® 2 2 7 3 . 9 1
III M, F - - 5 . 0 5 1
1/2 -
1 . 9 3
1 . 9 3
- 1 . 9 3 1 . 7 3 - -
to
®Value obtained from a single LP concentration.
TABLE 10
PHYSICAL CHEMICAL CHARACTERIZATION OF HUMAN PLASMA
























I M, F 1.0266 7.30 7.49 8.31 2.10 1.83 209 3.23
II M, F 1.0266 7.35 7.24 8.92 - - 215 3.21
CO
TABLE 11
PHYSICAL CHEMICAL CHARACTERIZATION OF HUMAN PLASMA



















1.0335 8.25 7.44 5.90 194 2.77
I M, F 2.11 1.84
1.0310“ 11. l“ 10.67“ 244“ 4.10“
II M, F 1.0329 8.30 8.69 6.90 2.10 1.83 208 3.24
“Minor component due to incomplete removal of rabbit proteins added as anti-human ApoA-LP (d > 
1.25 g/ml) for purification of the fraction.
TABLE 12
PHYSICAL CHEMICAL CHARACTERIZATION OF HUMAN PLASMA









































O  1.006-1.009 Preparation = 1.0016 g/ml
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Figure 36. Determination of hydrated densities of ApoB-LP Fraction I of two preparations.
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centrations of lipoproteins would merely give slightly different slopes 
of the straight lines of S and Sf versus p with an axis located at the 
same point of zero sedimentation. That the hydrated density of the male 
LP sample is lower than that of the female is to be expected, since the 
triglyceride content of male LP is known to be higher than that of fe­
male, and it is the relative triglyceride content which controls the den­
sity.
Figures 37 and 38 demonstrate the determination of hydrated den­
sities of ApoB-LP Fractions II and III, each of which was obtained at two 
separate occasions (preparations I and II). Both preparations were iso­
lated from a sample consisting of plasma from both sexes. Fraction II 
isolated at density range 1.009-1.019 g/ml gave hydrated densities of 
1.013 and 1.012 g/ml, respectively. Fraction III, isolated at 1.019-1.030 
g/ml gave values of 1.018-1.019 g/ml. Again, slight variations between 
two preparations isolated at the same density indicate differences in the 
triglyceride content and the lipoprotein distribution between the two 
groups of donors.
A third preparation of Fraction II is shown in Figure 39. The 
lipoprotein was isolated from male plasma. The hydrated density value 
is considerably lower than those of the other two preparations. This ob­
servation is consistent with the results of Fraction I; due to a higher 
triglyceride content the hydrated density of male lipoprotein is lower 
than that of female lipoprotein for the same isolation density range.
Figure 40 illustrates the determination of hydrated densities of 
ApoB-LP Fractions IV, 1.030-1.040 g/ml and V, 1.040-1.053 g/ml obtained 
from two different plasma samples. Both samples consisted of a mixture
o  1.009-1.019 -»■ a: = 1.013 g/ml 
e 1.019-1.030 -» a: = 1.019 g/mi
sn
£n
1.000 1.0601.010 1.020 1.040 1.030 1.070 1.0801.030
-400
SOLVENT DENSITY, p g/ml
Figure 37. Determination of hydrated densities of ApoB-LP Fractions II and III (Preparation I),
5
O  1.009-1.019 d = 1.012 g/ml
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00o
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Figure 39. Determination of hydrated density of ApoB-LP Fraction II, 1.009-1.019 g/ml, (Prepa­
ration III, è).
^£n
O  Preparation I
O  Preparation II
•  Preparation I + d =  1.0335 g/ml
0  Preparation II d = 1.0329 g/ml
1.030-1.040 g/ml -»■ d = 1.0266 g/ml
1.040-1.053 g/ml
1,000 1.010 1.020 1.030 1.040 1.050 1.060 1.070 1.080
CD
SOLVENT DENSITY, p g/ml
Figure 40. Determination of hydrated densities of ApoB-LP Fractions IV, 1.030-1.040 g/ml and 
V, 1.040-1.053 g/mJ.
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of plasma from both sexes. Sedimentation and flotation coefficients of 
both preparations of Fraction IV had identical values indicating that 
the lipoproteins of this density range possessed the same distribution 
for both preparations. The hydrated -̂ nsity value was found to be 1.0266 
g/ml. However, Fraction V showed si' ..'t differences between the two 
preparations (1.0329 g/ml and 1.0335 g/ml, respectively), even though 
both were isolated : :om the same plasma pools as the Fraction IV prepa­
rations.
Figure 41 shows the determination of hydrated densities of ApoB- 
LP Fraction VI (1.053-1.063 g/ml) from two preparations. One preparation 
was from both sexes, and the other was from female donors only. The 
graph of the female preparation lies to the right of that of a mixed prep­
aration. The hydrated density of the female sample was 1.0420 g/ml, and 
that of the mixed sample was 1.0357 g/ml. The observation that hydrated 
density values of lipoproteins isolated at any given isolation density 
range are dependent on sex is consistent throughout this study. For the 
same density range, the hydrated density of a female lipoprotein is 
greater than that of a male lipoprotein. The hydrated density of a mixed 
lipoprotein represents then the average value between that of female and 
male, depending on the proportion of the sample contributed by each sex.
Since the partial specific volume of a lipoprotein is the recip­
rocal of the hydrated density, the values for partial specific volume ob­
tained in this study are also dependent on sex. Female lipoproteins have 
a lower value than male lipoproteins isolated under identical conditions. 
’’Mixed" lipoproteins possess an intermediate value.
Determination of diffusion coefficients. Diffusion experiments
10
10
o  Preparation I &, + d = 1.0357 g/ml
*  Preparation II f", -»■ 3" » 1.0420 g/ml
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SOLVENT DENSITY, p g/ml
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were performed with every ApoB-LP subtraction except Fraction I, 1.006- 
1.009 g/ml and Fraction (I + II), 1.006-1.019 g/ml. Because of the ex­
tremely low hydrated density values of these two subtractions, it was 
difficult to obtain the sedimenting boundary in a salt solution required 
for such determination.
The apparent diffusion coefficient, Dgppj which is measured from 
the instant when the synthetic boundary is formed, changes slightly with 
concentration and with time. Figure 42 shows that Dapp a linear func­
tion of reciprocal time for different concentrations of ApoB-LP Fraction 
IV, 1.030-1.040 g/ml. Different concentrations of the same sample have 
a tendency to converge at the zero time. Figure 43 demonstrates the con­
centration dependence of the apparent diffusion coefficient, Dgpp. The 
apparent diffusion coefficient extrapolated to infinite dilution, Dgpp’ 
was 2.06 X  10"^ cm^/sec. Figure 44 shows that Dgpp is also slightly con­
centration dependent for ApoB-LP Fraction V, 1.040-1.053 g/ml. The D°pp
7 2of this subfraction was 2.07 x 10” cm /sec. Figure 45 shows the deter­
mination of the apparent diffusion coefficient, D^pp, at zero time for 
ApoB-LP Fraction VI, 1.053-1.063 g/ml at two different concentrations. 
These two straight lines converge to the same point at zero time. There­
fore, Dapp becomes concentration independent. This phenomenon has been 
observed also in Fractions II and III.
Some ultracentrifugal diffusion patterns are shown in Figures 
46 and 47. A pattern representative for each ApoB-LP subfraction from 
II through VI is presented.
All apparent diffusion coefficients at infinite dilution are cor­
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Figure 42. Determination of apparent diffusion coefficient at zero time of ApoB-LP Fraction 
IV, 1.030-1.040 g/ml of different concentrations.
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Figure 43. Determination of of ApoB-LP Fraction IV, 1.030-1.040 g/ml.
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Figure 46. Ultracentrifugal diffusion patterns of ApoB-LP Frac­
tion II (A), Fraction III (B), and Fraction IV (C).
Experimental conditions : synthetic boundary cell; temperature
25“C; solvent density 1.004 (A), 1.002 (B), and 1.003 g/ml (C). Pictures 




Figure 47. Ultracentrifugal diffusion patterns of ApoB-LP Frac­
tion V (A) and Fraction VI [B).
Experimental conditions; synthetic boundary cell; temperature 
25®C; solvent density 1.003 g/ml (A), 1.015 g/ml (B). Pictures were taken 
at 48, 64, 80, 96 and 112 minutes (A), and 0, 16, 32, 48 and 64 minutes 
(B) after the desired speed (12,590 rpm) was attained.
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6-12. The diffusion coefficients of each ApoB-LP subfraction differ very 
slightly (1.7-1.9 x 10^ cm^/sec).
Determination of average diameter. Average diameters of ApoB-LP 
subfractions were estimated according to the equation of Oncley and Gurd 
(131), assuming spherical particles:
4  = Dia.2 [12]
oWhere Dia. is the lipoprotein diameter in A. The values are presented in 
Tables 6-12.
Determination of molecular weight. Molecular weights were cal­
culated from the sedimentation and diffusion coefficients according to 
Svedberg's equation. Values of D^^ and V25 obtained experimentally 
at 25° were used. Since there was no necessity to use assumed values, 
the possibility of errors was greatly reduced. Where Sg^ was not avail-
gO gO
able, the value . was used as an equivalent for U--. The valid-
1 - VP 1 - Vp
ity of this assumption can be proved as follows: Figures 36-41 show that
plots of and versus solvent density, p, represented linear func­
tions for every subfraction studied. Hence within each subfraction
^  [13]d - P p - d
The value of p on the left side of equation [l3] is the solvent density 
at which S was measured. The value of p on the right is 1.063 g/ml. If 
each side of equation [l3] is multiplied by d
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Rearranging equation [l4] we obtain
L15]
By definition, V = 1—, therefore
d
^  [16]1 - Vp 1 - Vp
This equation would also be true for S and Sf at infinite dilution
L i 7 ]1 - Vp 1 - Vp
When  iD—  is used for 2— , the diffusion coefficient is also cor-
1 - Vp 1 - Vp
rected for viscosity of the solvent at 25°. The Svedberg equation is then
modified to
RTS°
^ “ D° (1 - 1.063 V)
If the diffusion coefficient was not available, the molecular weight was 
estimated according to Oncley's equation (16)
M = 0.317 d (Dia.)3 [l9]
where Dia. is the average diameter of the ApoB-LP subfractions calculated 
from Sj and d values as shown in equation [l2]. ■ •
The molecular weights calculated for each fraction are listed 
in Tables 6-12. A compiled tabulation of the physical data for all frac­
tions is given in Table 13. The values of each ApoB-LP subfraction are
TABLE 13



















I 1.006-1.009 1.0005 19.7 - - 250 383 4.9®
I, II 1.006-1.019 1.0030 19.1 2.96 - 244 381 4.6®
II 1.009-1.019 1.0125 16.2 5.14b 1.7 246 375 4.6
III 1.019-1.030 1.0185 12.7 5.63b 1.8 222 294-323 3.3-3.9
IV 1.030-1.040 1.0266 8.6 7.36 1.8 212 279 3.2
V 1.040-1.O53C 1.0329 6.9 8.30 1.8 208 275 3.2
VI 1.053-1.063 1.0357 5.5 8.60 1.9 194 243 2.9
v O
C O
*M.Wi calculated according to Oncley’s equation M = 0.317 d (Dia.) (16).
^Value obtained from a single LP concentration. 
"Only data of preparation II are included.
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averages calculated from data of several preparations from both male and
female donors. Values of  D—_ or  are also included.
1 - Vp 1 - VP
It is obvious that the hydrated density of ApoB-LP subfractions
increases with increasing isolating density. Flotation coefficient, Ŝ ,
decreases rapidly, while sedimentation coefficient, S^q increases at
a slower rate with increasing density. Diffusion coefficient, is
almost a constant, and the particle size decreases slightly. The ApoB-LP
subfractions fall into three distinct classes on the basis of data for 
0 0and with correction for buoyancy factor 1 - Vp and of molecular
weights. The first group includes Fractions I, I + II, and II, of iso-
r t O  q O
_ or fn_
1 -  Vp 1 -  vp
qO
lation density 1.006-1*019 g/ml. The values of  ̂ fall
within 375-383 for this group (with S° and expressed in Svedberg 
units). The molecular weights of these subfractions lie between 4.6-4.9 
X  1 0 ^ .  The second group is represented by Fraction III of isolation den­
sity 1.019-1.030 g/ml. It has a lower  En—  factor, ranging from 294-
1 - Vp
323. Correspondingly, its molecular weight lies between 3.3-3.9 x 10̂ . 
The third group is comprised of Fractions IV, V, and VI of isolation den­
sity 1.030-1.063 g/ml. This group has the lowest range of J ^IL_ values,
1 - Vp
243-279. Molecular weights range from 2.9-3.2 x 10&. The three groups
gO
show a steady decrease of or factors and of molecular
1 - VP 1 - VP 
weights with increasing density range of isolation.
It is believed that the molecular weight obtained for Fraction 
VI was slightly lower than the true value for ApoB-LP of this density 
range due to the presence of a small amount of ApoA-LP which could be re­
moved completely. Pure ApoB-LP of that subfraction should have given a 
value closer to 3.2 x 10^ g/mole.
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Amino Acid Composition 
Amino acid analyses were performed on the following subfractions: 
Fraction IV, 1.030-1.040 g/ml, Fraction V, 1.040-1.053 g/ml. Fraction VI, 
1.053-1.063 g/ml and a subfraction of ApoB-LP isolated in the density 
range 1.009-1.050 g/ml. This latter subfraction will be designated as 
Fraction A; it includes Fractions II, III, IV, and most of V. Triplicate 
analyses were determined on a 24-hour hydrolysate of each subfraction and 
standard deviations were calculated. In addition, a 72-hour hydrolysate 
of Fraction A was analyzed in duplicate. It was found that the contents 
of serine, threonine, and tyrosine decreased with increasing hydrolysis 
time. The initial content of these amino acids was obtained by a linear 
extrapolation to zero time; serine showed an increase of 3.74%, threonine 
5.10% and tyrosine 1.80% over those obtained after a 24-hour hydrolysis. 
Lysine, valine and isoleucine gave maximum values after a 72-hour hydrol­
ysis. These values represented increases of 5.(%, 6.2%, and 6.36%, re­
spectively, over those obtained with a 24-hour hydrolysate. Phospho- 
serine and cysteic acid could not be detected by the qualitative test de­
scribed in the Methods. The qualitative test for cysteine was also neg­
ative. Therefore the small peak shown on the amino acid analyzer at the 
position of cysteic acid must have been due to a slight oxidation of cys­
tine during hydrolysis. Half-cystine and methionine were determined as 
cysteic acid and methionine sulfoxide in the performic acid-oxidized pro­
tein. Tryptophan was determined spectrophotometrically in duplicate.
The amino acid compositions of the four fractions studied are given in 
Table 14. Correction factors for amino acids changing with hydrolysis 
time were calculated from data obtained with Fraction A. In all frac-
TABLE 14
AMINO ACID COMPOSITION OF THE PROTEIN MOIETIES OF HUMAN PLASMA
ApoB-LP FRACTIONS A, IV, V AND VI




1,009-1.050 1.030-1.040 1.040-1.053 1.053-1.063
Amino
Acid M/10^ g + o M/iO^ g + o m/iO^ g ± a M/lO^ g ± 0 M/lO^ g
Lysine 349.38 + 1.68 54.99 + 6.20 57.02 + 0.69 55.72 d- 3.11 55.91
Histidine 17.51 + .89 21.69 + 1.02 18.16 + 0.29 a 7.69 d- 0.67 19.12
Arginine 21.91 d- 1.80 20.18 + 3.23 23.82 + 3.46 18.73 d- 0.49 21.16
Aspartic Acid 86.33 + 3.36 90.30 + 1.80 88.07 + 7.92 88.86 d- 0 88.39
Threonine 54.57 + 2.13 51.96 + 0.31 51.55 + 0.93 56.20 d- 0.50 53.57
Serine 67.01 + 1.88 69.12 + 1.87 62.10 + 1.11 60.04 d- 3.0 64.57
Glutamic Acid 102.03 + 2.66 95.35 + 2.56 99.78 + 0.99 102.31 d- 1.43 99.87
Proline 29.22 + 1.54 33.30 + 2.06 29.29 + 1.26 27.86 d- 0.73 29.92
Glycine 36.46 + 0.91 45.40 + 0.77 43.15 + 1.72 50.43 d- 0.30 43.86
Alanine 52.16 + 1.25 55.49 + 0 60.73 d- 1.03 61.00 d- 2.14 57.35
Half Cystine 4.47 “ 7.06 4.69 6.24 5.61
Valine 37.67 + 1.32 35.31 + 0.53 36.52 d- 4.12 39.87 d- 1.04 37.34
Methionine 12.07 10.59 11.72 12.49 : 11.72
Isoleucine 39.84 + 1.31 35.31 + 0.53 37.49 + 0.52 40.04 d- 0.28 38.17
Leucine 90.92 + 1.91 85.76 + 2.31 82.99 d- 0.99 86.46 d- 0.95 86.53
Tyrosine 24.87 + 0.32 I 24.72 + 0.79 23.82 d- 0.31 24.02 d- 1.30 24.36
Phenylalanine 36.58 + 0.72 35.31 + 1.34 33.78 d- 0.30 35.06 d- 0.29 35.18
Tryptophan 5.07 3.03 6.44 5.18 4.93
vO
O '
Not included in the calculation of average.
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tions, glutamic acid, leucine, and aspartic acid are present in highest 
amounts, and cystine, tryptophan, and methionine are present in lowest 
amounts. Standard deviations for most of the values are less than 3%. 
However, greater variability (8-14%) in the determinations of lysine, 
arginine and histidine has been observed in most of the fractions. Am­
monia was not determined.
The results of amino acid analyses of all subfractions were 
critically compared. Except for lysine in Fraction A, histidine in Frac­
tion VI and glycine in Fractions A and VI, the amino acid compositions of 
all subfractions appear to be identical. The variations in the content 
of lysine, histidine and glycine most probably reflect the experimental 
difficulties rather than intrinsic differences in the amino acid compo­
sition of the samples. An average value has been calculated for each 
amino acid residue, the averages representing the amino acid composition 
of apolipoprotein B of low-density lipoproteins.
The results of glucosamine determinations are presented in Table
15. Values are expressed as percentages of apolipoprotein B dry weight. 
Fraction III, 1.019-1.030 g/ml and Fraction IV, 1.030-1.040 g/ml appear­
ed to have a higher content than the other fractions. The significance 
of these differences is not known at the present time.
Other Studies on Delipidized ApoB-LP 
Preliminary studies were carried out on solubilized ApoB. A 
protein residue obtained by mild delipidization of /^oB-LP Fraction IV, 
1.030-1.040 g/ml, was found to be partially soluble in Tris buffer, pH 
8.3, p 0.1, at room temperature. Ultracentrifugal study showed that the 
®20,w value for this compound was 2.57. Viscosity of the Tris buffer
TABLE 15
GLUCOSAMINE CONTENT OF HUMAN PLASMA ApoB-LP
' FRACTIONS A, III, IV, V AND VI
Fraction A III IV V VI vO00
Density Range g/ml 1.009-1.050 1.019-1.030 1.030-1.040 1.040-1.053 1.053-1.063
Weight percent of ApoB 1.45 2.12 3.16 1.52 1.53
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measured to be 1.019 relative to that of water at 25° by using an Ostwald 
viscometer. The protein solution was then heated slowly in a sand bath 
for one hour at 80°. The apparent solubility increased substantially.
The sedimentation value, SgiQ,#» °̂  the heated protein was found to be 
2.39. Another sample of the same protein was solubilized in a 0.018 M 
NaOH and 0.15 M NaCl solution, pH 12, 0.17, by heating slowly for 20
minutes at 70°. The solubility of the protein appeared to be even greater 
than in Tris buffer. The sedimentation coefficient, was found to
be 2.43. The value for sedimentation coefficient increased slightly at 
infinite dilution. Apolipoprotein B obtained by vigorous delipidization 
of ApoB-LP Fraction IV was then investigated. It was solubilized suc­
cessfully in the NaOH-NaCl solution at pH 12 but with heating for 30 min­
utes at 37°. Sedimentation and diffusion coefficients of this sample 
were determined at infinite dilution. The pH of the protein solution 
was then adjusted to 7 by adding HCl. The final solventr became 0.17 M 
NaCl of density 1.0063 g/ml. Sedimentation and diffusion coefficients 
of this solution were also determined and the results are shown in Table
16.
Figures 48 and 49 show the determination.df sedimentation coef­
ficients of ApoB at pH 12 and pH 7, respectively. The two slopes of
d ÏD X are almost parallel to each other. Figure 50 illustrates the ul- dt
tracentrifugal sedimentation patterns of three sedimentation experiements 
on ApoB: at pH 8.3 with heating for one hour at 80°, at pH 12 with heat­
ing for 30 minutes at 37°, and at pH 7 after solubilization at pH 12.
Each sedimentation pattern indicates a single, symmetric peak. Figure 
51 shows the ultracentrifugal diffusion pattern of ApoB in dilute alkaline
TABLE 16
PHYSICAL-CHEMICAL CHARACTERIZATION OF V^oB UNDER VARIOUS
CONDITIONS OF SOLUBILIZATION
Sample ApoB-LPFraction













temperature 2.57® — -
A IV 8.3
Tris
buffer 0.1 1.0011 80°C, 1 hr. 2.39* - -
A (1 dil.) IV 12
NaOH + 





NaCl 0.17 1.0043 37°C, 30 min. 2.47® 4.00®
B (i dil.) IV 12
NaOH -t 
NaCl 0.17 1.0043 37°C, 30 min. 2.56® 3.72* —
B (i dil.) IV 12
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NaCl 0.17 1.0043 37°C, 30 min. 2.65 3.44 7.0
B IV 7 NaCl 0.17 1.0063 37°C, 30 min. 2.44® 4.93® -
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Figure 48. Determination of S of Apolipoprotein B obtained 
from ApoB-LP Fraction 1.030-1.040 g/ml. Protein was dissolved in 0.018 M 
NaOH and 0.15 M NaCl (p = 1.0043 g/ml) at 37°C for 30 minutes. Measure­
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Figure 49. Determination of S of Apolipoprotein B obtained 
from ApoB-LP Fraction 1.030-1.040 g/ml. Protein was solubilized in 
0.018 M NaOH and 0.15 M NaCl at 370C for 30 minutes and then pH reduced 
to 7 with HCl Cp = 1.0063 g/ml). Measurements were taken after the rotor 





Figure 50. Ultracentrifugal sedimentation patterns of ApoB.
A: ApoB from ApoB-LP Fraction IV, 1.030-1.040 g/ml, in 0.1 M 
Tris buffer, pH 8.3, with heating for one hour at 80*. B: ApoB from 
the same lipoprotein, in 0.018 M NaŒ and 0.15 M NaCl, pH 12 with heat­
ing for 30 min. at 37*. C: Same protein as in pattern B with pH re­
duced to 7. Experimental conditions: rotor speed 59,780 rpm; temper­
ature 25*. Pictures were taken from left to right at 4-minute inter­
vals after full speed was attained.
Figure 51. Ultracentrifugal diffusion pattern of ApoB.
Protein, solvent and treatment are the same as in pattern B of 
Figure 50. Pictures were taken from left to ri^t at 4-minute intervals 
after desired speed was attained (12,590 rpm).
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solution at pH 12 with heating at 37°C.
Table 17 shows the partial specific volume, V, of ApoB calcu­
lated from the weight percentages of the amino acids. The values for 
partial specific volumes of each amino acid residue were taken from Cohn 
and Edsall (l32). The calculated V of ApoB was 0.733 ml/g. Since the V 
values for both asparagine and glutamine are very close to those of 
aspartic acid and glutamic acid, it was decided not to make an assumption 
on the distribution of ammonia between glutamic and aspartic residues.
The molecular weight of ApoB, estimated from S, D and V was 7.0 x 10 .
This value was correlated with the amino acid composition and the nearest 
integral number of residues of each amino acid in a mole of protein was 
estimated. Results are shown in Table 18. Molecular weight summarized
4from the weight of amino acids is 7.07 x 10 .
Figure 52 shows the immunochemical properties of ApoB solubilized 
in Tris buffer, pH 8.3, p 0.1, at room temperature and after heating for 
one hour at 80°. ApoB under both conditions gave two precipitin lines 
against rabbit serum containing antibodies to human ^oB-LP. One of the 
two precipitin lines was identical to that of ApoB-LP. However, the ApoB 
solubilized in dilute alkaline solution with heating failed to show any 
reaction against the same antiserum.
Figure 53 shows the electrophoretic mobility of ApoB on cellu­
lose acetate paper. It is noted that ApoB solubilized at pH 12 showed a 
single band with Og-mobility, regardless of the final pH. ApoB solubil­
ized in Tris buffer at room temperature gave 2 bands; however, after 
heating to 70° the same sample gave a single band with electrophoretic 
mobility slower than that of the samples resolubilized at pH 12. The
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TABLE 17 
PARTIAL SPECIFIC VOLUME OF ApoB
Amino Acid m/10^ g Wt. % V ml/g V,* Wt. %
Lysine 55.91 8.12 0.82 6.66
Histidine 19.12 2.95 0.67 1.98
Arginine 21.16 3.66 0.70 2.56
Aspartic Acid 88.39 11.68 0.60 7.01
Threonine 53.57 6.34 0.70 4.44
Serine 64.57 6.74 0.63 4.25
Glutamic Acid 99.87 14.59 0.66 9.63
Proline 29.92 3.42 0.76 2.60
Glycine 43.86 3.27 0.64 2.09
Alanine 57.35 5.07 0.74 3.75
Half Cystine 5.61 0.67 0.63 0.42
Valine 37.34 4.34 0.86 3.73
Methionine 11.72 1.74 0.75 1.31
Isoleucine 38.17 4.97 0.90 4.47
Leucine 86.53 11.27 0.90 10.14
Tyrosine 24.36 4.38 0.71 3.11
Phenylalanine 35.18 5.77 0.77 4.44
Tryptophan 4.93 1.00 0.74 0.72
V of ^oB = 2V • Wt. % = 0.733 ml/g.
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TABLE 18 
AMINO ACID COMPOSITION OF ApoB



















Nearest integral no. of amino acid residues based on the molec­
ular weight obtained by physical-chemical method.
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Figure 52. Immunochemical properties of ApoB in Tris buffer.
Center well: rabbit serum containing antibodies to human ApoB- 
LP. A, B: ApoB solubilized in 0.1 M Tris buffer, pH 8.3. C, E: ApoB 
solubilized in 0.1 M Tris buffer, pH 8.3, by heating for one hour at 80°. 
D: ApoB-LP. Note 2 precipitin lines at A, B, C, and E. One of the pre­
cipitin lines is identical to that of D.
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A B C D E  F G H
Figure 53. Cellulose acetate electrophoretic pattern of ApoB 
under various solubilization conditions.
A: ApoB from ApoB-LP, 1.019-1.053 g/ml, at pH 1, solubilized
at pH 12 with heating for 30 min. at 75°, pH reduced to 1 with IKl; B:
same protein as A but at pH 7; C: ApoB from ApoB-LP Fraction IV, 1.030-
1.040 g/ml, at pH 12, solubilized by heating 20 min. at 70°; D: same
protein as A at pH 12; E: ApoB from ApoB-LP Fractions I + II, 1.006- 
1.019 g/ml, solubilized in 0.1 M Tris buffer, pH 8.3, with heating for 
10 min. at 70°; F: same protein as C but solubilized in 0.1 M Tris buf­
fer at room temperature; G: ApoB-LP, 1.019-1.040 g/ml; H: human whole
serum. Mobilities: A, B, D migrated as ag-globulin, C as ai-globulin,
E stayed at origin, F at origin and at g-globulin and ApoB-LP migrated 
as 3-globulin.
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protein solutions A, B, D, and F were also subjected to high voltage 
electrophoresis. No amino acids were observed in samples A, B, and D. 
However, glutamic acid, aspartic acid, and some neutral amino acids were 
observed in protein F solubilized in Tris buffer. This same protèï^ (C) 
solubilized in NaOH and NaCl at pH 12 migrated further (to an o^-position) 
than other similarly treated proteins. This indicates that this partic­
ular protein was degraded before it was solubilized.
CHAPTER IV
DISCUSSION
Heterogeneity of Ultracentrifugal Isolates of LDL 
It has long been assumed that ultracentrifugal preparations of 
LDL are homogeneous with respect to protein moiety. Apolipoprotein B 
has been considered to be the only protein present in the low-density 
lipoprotein range. It was not until 1963 that Freeman et (23) found 
a high-density lipoprotein (HDL^) present in the highest density range 
of LDL. No further characterization of this HDL̂  ̂has been reported.
Nearly all the workers studying /^oB-LP still use the solvent density 
range 1.006-1.063 g/ml as the criterion for isolating pure ApoB-LP. Most 
methods currently in use for determining the homogeneity of the protein 
moiety of LDL are not sensitive enough to detect the small amounts of 
ApoA-LP present. It has been demonstrated in this study that electropho­
resis on cellulose acetate, on starch gel, and even Immunoelectrophoresis 
all fail to detect the trace amount of ApoA-LP. Since analytical ultra­
centrifuge shows a single symmetric peak at reasonable lipoprotein con­
centration for any LDL fraction, this has been considered as a reasonable 
indication for the homogeneity of LDL. Only in highly dilute solution 
would the broadening or assymetry of a peak become apparent in a schlieren 
pattern. However, since LDL itself is a polydisperse system, a broadened
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peak would not necessarily lead to the conclusion that ApoA-LP was pres­
ent.
The antigenicity of ApoB-LP is much greater than that of ApoA- 
LP. When human LDL are used for immunizing rabbits ^oA-LP antibodies 
appear much slower than ApoB-LP antibodies. Therefore, the homogeneity 
in the antibody production within a certain time limit does not necessar­
ily indicate the homogeneity of antigen. Even when a whole human serum 
is used for immunization the concentration of ApoA-LP antibodies produced 
is generally too weak to detect the small amount of ApoA-LP in the LDL 
range. For this reason, rabbit serum containing antibodies to human ApoA- 
LP rather than that containing antibodies to human whole serum has been 
used throughout the present study. It is probably for the same reason 
that conflicting findings on antigenicity of the LDL are reported in the 
literature. Gitlin et aĵ. (68), Aladjem et â . (12, 69), and Lawrence 
et al. (70) have found antigenic heterogeneity, while Korngold et 
(65), Levine (67), Scanu et (71), and Blumberg et al. (73) have re­
ported antigenic homogeneity of LDL.
It was found that the ApoA-LP detectable in samples by the micro 
immunodiffusion technique, as described in Methods, was not observed when 
Petri dishes were used for immunodiffusion experiments.
Since washing by recentrifugation did not remove ApoA-LP from 
the LDL fractions completely, it is suggested that the ApoA-LP found in 
the LDL range was not a contaminant, but rather a lipoprotein with a hy-r 
drated density characteristic of the LDL range (1.006-1.063 g/ml). How­
ever, the amount of ^oA-LP within the LDL range is sufficiently small 
to render quantitative study very difficult.
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It has been noticed frequently that the removal of traces of 
ApoA-LP resulted in a decreased stability of ApoB-LP solutions as shown 
by an increased rate of turbidity formation. The significance of the 
ApoA-LP presence in LDL is not known. It appears that, similarly to al­
bumin, it may serve as a stabilizing agent for ApoB-LP.
Chemical Composition and Phvsical-Chemical 
Characterization
Results of the chemical analysis of ApoB-LP subfractions were 
compared with those reported in the literature. The composition of ApoB- 
LP Fraction I (Table 5) is surprisingly close to that of a subfraction 
isolated at the density 1.006-1.019 g/ml (Table 3) by Korn (76). For the 
higher density ranges of LDL, the results of the present study show good 
agreement with most of the data in the literature. Exceptions are the 
results of Lindgren et al. (81) which varied considerably from the values 
in other literature reports, and the rather low protein and phospholipid 
values reported by Smith (83). It is interesting to note (Table 5) that 
within the density range 1.019-1.063 g/ml, the phospholipid and protein 
values do not increase with increasing density, but remain rather con­
stant. The phospholipid/protein ratio is a constant in all subfractions 
from d 1.006 g/ml to 1.063 g/ml, in spite of the fact that the total phos­
pholipid and protein values are lower in the first subfraction. The re­
sults reported in the literature confirm this finding. The neutral lipid 
content of the last four fractions (1.019-1.063 g/ml)represents also a 
rather constant value [neutral lipid = 100 - (phospholipid+protein)].
Since the free cholesterol content is practically independent of density, 
it is the cholesterol ester/triglyceride ratio that controls actually the
113
density of low-density lipoproteins. The neutral lipid/phospholipid-pro- 
tein ratio of the ApoB-LP subfractions have two distinct values: 1.90
for the first fraction and approximately 1.18 for the last four fractions. 
The content of triglyceride is higher than that of cholesterol ester in 
the first fraction and the opposite is true for the last four fractions.
It is regrettable that the values for Fraction II are lacking. However, 
by comparison with a study compiled by Korn on the LDL subfraction of d 
1.006-1.019 g/ml (76), one would expect that the neutral lipid/phospho- 
lipid-protein ratio of Fraction II, 1.009-1.019 g/ml, would be closer to 
that of Fraction I, 1.006-1.009 g/ml than to that of higher density frac­
tions.
The correlation between the increased hydrated densities of 
ApoB-LP subfractions and the decreased values found in the present 
study agrees very well with the report of Lindgren et al. (19). No stud­
ies have been reported in the literature regarding the comparison of the 
hydrated density, and flotation and sedimentation coefficients between 
female and male lipoproteins isolated at the same solvent densities. It 
has been demonstrated that the hydrated densities of all male ApoB-LP 
subfractions are consistently lower than those of female lipoproteins. 
Despite the variations in hydrated densities, sedimentation and flotation 
coefficients, and diameter of the particles between male and female lipo­
proteins isolated at the same density range, molecular weights are the 
same for similarly isolated preparations regardless of sex (Tables 8 and 
12). This suggests that the molecular weights could be identical for 
any lipoproteins of different hydrated densities, even those isolated at 
different solvent densities. Indeed, the molecular weights of ApoB-LP
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Fractions IV, V and VI are the same, as are those of ApoB-LP Fractions I,
I + II and II. Fraction III appears to have an intermediate value.
One of the preparations of ApoB-LP Fraction III had a hydrated 
density of 1.019 g/ml and a molecular weight of 3.3 x IcA, while another 
preparation of the same subfraction with a hydrated density of 1.018 g/ml 
possessed a molecular weight of 3.9 x 10̂ . Thus, these two preparations 
differed slightly in their hydrated densities, but appreciably in their 
molecular weights. Since subfractions of ApoB-LP can be separated into 
two groups characterized by molecular weights of 4.6 x 10̂  and 3.2 x 10̂ , 
it would appear that the dividing line between these two groups must be 
within the hydrated densities 1.018-1.019 g/ml.
The values for "hydrated densities" of lipoprotein subfractions 
isolated within a certain solvent density range represent actually average 
hydrated densities of all lipoprotein molecules occurring in that partic­
ular density range. The true hydrated densities of individual lipoprotein 
molecules must lie on both sides of an average value. Therefore, lipo­
proteins of ApoB-LP Fraction III with average hydrated densities of 1.018 
and 1.019 g/ml contain certain number of molecules with true hydrated 
density values lower and higher than those of their average hydrated den­
sity. It is postulated, on the basis of results obtained in this study, 
that the intermediate subfractions of ApoB-LP represent mixtures of lipo­
proteins of only two molecular weights, 4.6 x 10^ and 3.2 x 10̂ , rather 
than of molecules characterized by many gradually changing molecular 
weights. The variation in the percent distribution of these two groups 
of lipoprotein molecules results in preparations characterized by molec­
ular weights falling within the two extreme values.
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There is an excellent agreement (Table 13) between values for 
the molecular weight of various LDL subfractions reported in this study 
and in the literature regardless of some important differences in the 
isolation and purification procedures.
Despite differences in the flotation and sedimentation coeffi-
ncients the values for terms IL__ or (S° and s2, corrected for1 - Vp 1 - Vp
buoyancy factors) for ApoB-LP Fractions IV, V and VI (Table 13) are the 
same (the lower value for ApoB-LP Fraction VI is due to the presence of 
small amount of /^oA-LP). This result indicates clearly that the vari­
ation in the sedimentation and flotation coefficients at infinite dilu­
tion depends only on the buoyancy factor which is, in turn, controlled 
exclusively by the hydrated density of lipoprotein subfractions. It fol- 
fows then that lipoprotein molecules of ApoB-LP subfractions isolated at 
different density ranges must have the same shape. Since the diffusion 
coefficients of all three subfractions have almost identical values, the 
molecular weights calculated according to the Svedberg's equation at con­
stant temperature, must be also identical.
The results of the chemical composition of ApoB-LP subfractions 
seem to favor the conclusion that the Fraction III should have most prob­
ably the same molecular weight as Fractions IV, V and VI, since its neu­
tral lipid/phospholipid-protein ratio is in the same range. If all four 
subfractions consisted of the same basic phospholipid-protein structural 
unit, their molecular weights would be expected to have similar or iden­
tical values.
A comparison of chemical composition between certain subfrac­
tions of LDL from this study and that of Korn (76) and an apolipoprotein
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B-containing VLDL (Sf 20-50) isolated and characterized by Gustafson et 
al. (20) discloses that the phospholipid/protein ratio is very similar, 
if not identical, for all apolipoprotein B-containing lipoproteins of 
different densities or classes (Table 19). On the other hand, the values 
for the neutral lipid/phospholipid-protein ratio differ for three major 
density groups of apolipoprotein B-containing lipoproteins; the density 
subfractions Sf 20-50, 1.006-1.019 g/ml and 1.019-1.063 g/ml are charac­
terized by ratios 3.0, 2.0 and 1.18, respectively. Similarly, the molec­
ular weight of these subfractions decreases with increasing density. 
However, the calculated molecular weight of the phospholipid-protein 
structural units of all these subfractions is 1.5 x 10̂ . This indicates 
that the absolute amount of phospholipid-protein unit is constant in all 
subfractions of apolipoprotein B-containing lipoproteins thus far stud­
ied. Therefore, it is postulated that each segment of the polydisperse 
system of ApoB-LP consists of the same basic phospholipid-protein struc­
tural unit. The increase in size and molecular weight of ApoB-LP sub­
fractions is due solely to the increased amount of triglycerides or tri­
glycerides and cholesterol esters. A further support for this hypothesis 
will be forthcoming from the discussion of studies on the protein moiety.
It appears from this study as well as from literature reports 
that the absolute amount of free cholesterol remains also quite constant 
in every ApoB-LP subfraction. Since free cholesterol can be removed 
more readily than phospholipid by partial delipidization (51, 109), it 
is not quite clear whether it is directly bound to the protein or whether 
it represents a "bridge" between the inner core of triglyceride and 
cholesterol ester and the outside shell or membrane composed of protein-
TABLE 19

















PL + PR 
xlO-G
Reference
VLD Sf 20-50 B 1.10 3.0 6.0 1.5 (20)
I, 1.006-1.009 B 0.97 1.9 4.9 1.69 a
I + II, 1.006-1.019 B 1.20 2.0 4.6® 1.5 (76)
IV, 1.030-1.040 B 0.96 1.18^ 3.2 1.5 a
®Data from present study.
^Average value of Fraction III - VI.
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phospholipid units.
The results of amino acid analysis of ApoB-LP subfractions are 
generally in excellent agreement with those reported by Margolis and 
Langdon (95). The only significant difference (20̂ ) is found in the con­
tents of alanine, valine and isoleucine. This similarity in the amino 
acid composition of apolipoprotein B-containing lipoproteins covering 
flotation ranges such ^  10-400 (95) or 5-16 (present study) could
be interpreted as another evidence for the possible identity of protein 
moieties and, indirectly, the phospholipid-protein units of ApoB-LP sub­
fractions.
Results of amino acid analysis confirm also the already avail­
able evidence (lOO, 113, 134) for a difference between the amino acid 
composition of ApoA and ApoB. The striking difference between these two 
proteins was noticed primarily in their content of isoleucine, aspartic 
acid and phenylalanine.
Physical-Chemical Studies on Apolipoprotein B
This study describes also the first attempt to redissolve a to­
tally delipidized ApoB-LP in absence of additives and to determine the 
sedimentation and diffusion coefficients, and the molecular weight of 
apolipoprotein B. Granda and Scanu (101) have demonstrated the feasibil­
ity of solubilizing the apolipoprotein B by a method of total delipidiza­
tion of /̂ )oB-LP in the presence of sodium dodecyl sulfate. However, 
these authors obtained a sedimentation value which appeared to be too 
high for a protein deprived of lipids. Since sodium dodecyl sulfate forms 
a complex with the apolipoprotein B, such a "model" offers little or no 
advantage for physical-chemical characterization of the protein moiety.
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In order to avoid the use of complex-forming, solubilizing 
agents, a study of apolipoprotein B solubility in dilute alkaline solu­
tions has shown that the protein moiety is fairly soluble in both Tris 
buffer, pH 8.3, and in a 0.018 M NaOH solution, pH 12, at 70-80°. The 
similarity in the sedimentation coefficients of apolipoprotein B solu­
tions indicated little or no effect of pH-values on the structure of pro­
tein moiety. Short heating intervals, up to 20-30 minutes, resulted in 
no detectable degradation fragments such as small peptides or amino acids 
as tested by high voltage electrophoresis or two-dimensional thin-layer 
chromatography of apolipoprotein B solutions.
The preliminary study shows that the molecular weight of apo­
lipoprotein B dissolved in 0.018 M NaOH solution, pH 12, at 37° is 
7.0 X 10̂ . The smallest possible molecular weight calculated from the 
amino acid composition of apolipoprotein B is 3.5 x 10'̂ , assuming the 
presence of only one cystine residue. The theoretical value of the mo­
lecular weight based on the presence of two moles of cystine would cor­
respond exactly to the experimental value.
The appearance of a single peak at various concentrations of 
apolipoprotein B in the ultracentrifugal patterns, seems to indicate ab­
sence of impurities and aggregates. If a molecular weight of 7.0 x lO'* 
represents the smallest protein unit and the average value for the phos­
pholipid/protein ratio is close to unity, the molar weight of the protein 
moiety of all apolipoprotein B-containing lipoproteins must be approxi­
mately 7.5 X  10^ (calculated from the molar weight of phospholipid-pro­
tein unit, 1.5 X 10̂ , Table 19). The apolipoprotein B consists then of 
ten or eleven identical subunits.
CHAPTER V
SUMMARY
Human plasma low density lipoproteins (LDL) of normal subjects 
were separated by sequential preparative ultracentrifugation into six 
arbitrary subfractions (d 1.006-1.009, 1.009-1.019, 1.019-1.030, 1.030- 
1.040, 1.040-1.053 and 1.053-1.063 g/ml). Small amounts of apolipopro­
tein A-containing lipoproteins associated with this density range were 
removed by immuno-precipitation. The homogeneous, apolipoprotein B- 
containing subfractions were characterized by immunochemical methods, by 
cellulose acetate and starch gel electrophoresis, by chemical and amino 
acid composition, by determination of hydrated density, sedimentation, 
flotation and diffusion coefficients, and by estimation of particle dia­
meter and molecular weight.
All subfractions had practically the same diffusion coeffi­
cients (D20,w ~ i'7-i'9 X  10 ^ cm^/sec.). On the basis of gross chem­
ical composition, molecular weights, and sedimentation coefficients cor­
rected for solvent viscosity and buoyancy factors the LDL can be separ 
rated into two distinct groups occurring within the density ranges 1.006-
1.019 g/ml (Class I) and 1.030-1.063 g/ml (Class II). The lipoproteins 
of density range 1.019-1.030 g/ml represent a mixture of both major 
groups. Subfractions of both groups had a constant percentage of neutral
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lipids (triglyceride + cholesterol) and phospholipid and protein. The 
phospholipid/protein ratio of all subtractions was the same. Subtrac­
tions ot Class I and Class II were characterized by molecular weights 
ot 4.6 X 10^ and 3.2 x 10̂ , respectively. All subtractions had an iden­
tical total amount ot phospholipid and protein (1.5 x 10̂ ). An apolipo­
protein B-containing subtraction (Ŝ  20-50) ot VLDL was characterized 
by the same phospholipid/protein-ratio and the same absolute amount ot 
phospholipid and protein, even though the gross chemical composition 
and physical-chemical properties (molecular weight 6 x 10̂ ) were dif­
ferent from those ot LDL subtractions. It has been postulated, there­
fore, that each segment ot the polydisperse system ot apolipoprotein 
B-containing lipoproteins consists ot the same basic phospholipid-protein 
structural unit. The absolute amount ot this unit is practically con­
stant throughout the spectrum ot apolipoprotein B-containing lipopro­
teins and is characterized by the capacity to maintain the structural 
integrity ot triglyceride-cholesterol micelles ot different sizes and 
molecular weights. In support ot this hypothesis, it was found that 
the protein moiety ot each subtraction had an identical amino acid com­
position.
It has been demonstrated that apolipoprotein B can be solu­
bilized in the absence ot detergents. The sedimentation coefficient, 
^20,W» found to be 2.6 at various pH values and was not altered by 
heating the protein solution at 70°. The value tor the molecular weight 
ot apolipoprotein B calculated by Svedberg's equation was 7.0 x 10̂ . On 
the basis ot this finding, it has been concluded that the protein moiety 
(7.5 X 10^ g/mole) ot apolipoprotein B-containing lipoproteins consists 
ot ten or eleven identical subunits.
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LIST OF ABBREVIATIONS AND SYMBOLS 
English Letter Symbols 
ApoA Apolipoprotein A
ApoA-LP Apolipoprotein A-containing lipoproteins
/^oB Apolipoprotein B
ApoB-LP Apolipoprotein B-containing lipoproteins
app Apparent
CE Cholesterol esters
d Isolation density of lipoprotein fractions














LIST OF ABBREVIATIONS AND SYMBOLS— Continued
English Letter Symbols





S Observed sedimentation coefficient
S° Observed sedimentation coefficient at infinite
dilution
SpQ Sedimentation coefficient at infinite dilution
’ in water at 20°C
SDS Sodium dodecyl sulfate
Sf Flotation coefficient in NaCl solution of
>0
density 1.063 g/ml or of other densities
Sf Flotation coefficient at infinite dilution in
NaCl solution of density 1.063 g/ml at 26°C
Sved. Svedberg unit (lO"^^ second)
t Time in seconds
t Temperature in centigrade
T Absolute temperature in °K
TCA Trichloroacetic acid
TG Triglyceride
V Partial specific volupe
VHDL Very high-density lipoproteins
VLDL Very low-density lipoproteins
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LIST OF ABBREVIATIONS AND SYMBOLS— Continued





n Viscosity of solvent at 25°C relative to that
of water at 25°C
Viscosity of solvent at t°C 











THE DEFINITION AND ABBREVIATIONS FOR SERUM OR PLASMA LIPOPROTEINS
VLDL, very low-density lipoproteins, lipoproteins of d < 1.006 g/ml and
Sf > 20
LDL, low-density lipoproteins, lipoproteins of d 1.006-1.063 and Sf 0-20;
pLP, p-lipoproteins, lipoproteins displaying the mobility of p- 
globulin in free electrophoresis
^oB-LP, lipoproteins containing a single protein moiety, apolipoprotein 
B
HDL, high-density lipoproteins, lipoproteins of d 1.063-1.210 g/ml; aLP, 
a-lipoproteins, lipoproteins displaying the mobility of â - 
globulin in free electrophoresis
HDLg, subfraction of high-density lipoproteins of d 1.063-1.125 g/ml
HDLg, subfraction of high-density lipoproteins of d 1.125-1.210 g/ml
ApoA-LP, lipoproteins containing a single protein moiety, apolipoprotein 
A
VHDL, very high-density lipoproteins, lipoproteins of d > 1.210 g/ml
VHDL,, very high-density lipoproteins, lipoproteins of d 1.210-1.250 
g/ml







Program for Logarithm of X for, the Calculation of 









The distance between the sedimenting or flotating boundary and 
the reference hole in cm.
The distance between two reference holes in cm.
Average of B.
Answer in In X (X is the distance from boundary to the center 
of rotation in cm. at time t).
COMASR Answer in log X.
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C PROGRAM FOR LOGARITHM OF X FOR SEDIMENTATION




99 READ 1, N,M,K
1 FORMAT(315)
PRINT 2, K
2 F0RMAT(6X,14HPLATE NUMBER =,I5/)
READ 3, (A(J), J=1,N)
READ 3, (B(J), J=1,M)
3 F0RMAT(8F8.3)
PRINT 44, (A(J),J=1,N)








4 F0RMAT(/6X,12HB, AVERAGE =, F8.3/)
DO 11 J=1,N
11 ASR(J)=L0GF(1.6*A(j )/bA+5.72)
PRINT 5, (ASR(J), J=1,N)
5 F0RMAT(/6X,21HANSWER IN NATURE LOG , 5F12.5) 
DO 12 J=1,N
12 C0MASR(j)=ASR(j)/2.30259 
PRINT 6, (COMASR(J), J=1,N)
6 FORMAT(/6X,21HANSWER IN COMMON LOG , 5F12.5) 
PRINT 7
7 FORMAT(//////)





30.416 29.852 29.355 28.975 28.398 
33.934 33.902 33.935 33.952 33.932
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A test. NN < 1, program reads YF; NN > 1, program reads A. 
Number of measurements of H.
Plate number.
Picture number.
Time in minutes recorded for each picture.
Base line.
Measurement of boundary on y axis.
Time between the instant of boundary formation and the first 
picture taken.






PROGRAM OF DIFFUSION COEFFICIENT 
DIMENSION YF(IOO), H(lOO)







PRINT 5, IPN, IPICN, TM
5 FORMAT(lHl//////3X,6HPLATE ,I3,3H - ,I3,4X,
116HTIME INTERVAL = ,I3,6H MIN.///)
PRINT 6, HMAX
6 F0RMAT(3X, 7HHMAX = ,F10.6/)
IF(NN-1)10,10,13












101 FORMAT(3X,16H(a/HMAX/f )**2 = , F9.7/) 
TIME=12.5664*(60.0*TM+T0)
PRINT 102, A
102 FORMAT(3X,7HAREA = ,F10.6/)
PRINT 103,RATIO





PRINT 106, DAPP - -
106 F0RMAT(3X, 34HDIFFUSI0N COEFFICIENT, APPARENT = , E12.6/) 
PRINT 107, TIMRVS





1 24 606 2
21.807 4.000 492.000 .200 12590.000 10.487 21.395
,1760005-12
21.717 21.685 21.644 21.548 21.275 20.715 19.834
18.991 17.533 15.617 13.627 11.895 11.320 11.828
14.083 16.550 18.411 19.771 20.557 20.973 21.258 o21.473 21.604 21.699
